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Abstract
	   	  
	  
	  
	   	  
	  
	   xiii	  
Epithelial cells are characterized by their polarized organization, which entails two 
structurally and functionally distinct domains: apical and basolateral. Interestingly, the 
proteins that participate in the establishment and maintenance of apical-basal polarity are 
also important players in the regulation of the orientation of asymmetric and symmetric 
cell divisions. Using mouse epidermis as a model system, we studied the mechanisms 
underlying the regulation of the polarized organization and oriented cell divisions of the 
basal progenitor cells. In particular, we explored the role of Aurora kinase A (AurkA), 
whose roles in cell polarity has been demonstrated in the Drosophila neuroblast, but still 
poorly understood in mammalian tissues. Using mouse genetics, we have observed that 
heterozygous inducible conditional knock-out mice in the epidermis present alterations in 
the polarized organization of epidermal cells short upon AurkA reductions. This is 
accompanied by hyperplasia and a wave of increase in the proliferation of basal 
epidermal cells. The localization of apical proteins Par3 and aPKC is also lost and the 
number of oriented of cell divisions parallel to the epidermal layer is aberrant. In addition, 
the formation of adherens junctions and tight junctions, which is closely related to the 
acquisition and maintenance of apical-basolateral polarity, is aberrant in the absence of 
AurkA. Additionally, we discovered that the localization of the active form of AurkA 
mirrors that of the Par complex proteins both in vivo and in vitro, suggesting a role for 
AurkA in the maintenance of cell polarity in the epidermis.  Genetic ablation or chemical 
inhibition of AurkA leads to the mislocalization of the Par complex proteins in vitro. 
Knock down of AurkA in MDCK cells, a bona-fide model for studying apical-basal 
polarity, leads to the loss of aPKC from the cortex and malformation of 3-D cysts. 
Overall, our data suggest that AurkA also may play a role in the maintenance of apical-
basolateral polarity in the mammalian epidermis, in addition to its canonical role in cell 
cycle, extending the implications of its function in the maintenance of tissue homeostasis. 	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Las células epiteliales se caracterizan por presentar una organización subcelular polarizada, 
con dos dominios diferentes a nivel funcional y estructural: el dominio apical y el dominio 
basal. Resulta interesante observar que las proteínas implicadas en la formación y el 
mantenimiento de la polaridad apico-basal, desempeñan también un importante papel en 
la orientación de las divisiones celulares, de manera simétrica o asimétrica. En esta tesis 
hemos utilizado la piel de ratón como sistema modelo para estudiar los mecanismos que 
regulan la polaridad celular y la orientación de las divisiones de las células basales 
progenitoras. En concreto, hemos explorado el papel de la proteína Aurora Kinasa A 
(AurkA), la cual está implicada en la regulación de la polaridad de los neuroblastos de 
Drosophila, pero su contribución a la polaridad celular en tejidos de mamífero se 
desconoce. Utilizando modelos de ratón modificados genéticamente, hemos observado 
que ratones heterocigotos “knock-out” condicionales-inducibles en la epidermis para 
AurkA, presentan alteraciones en la polaridad de las células de la epidermis como 
consecuencia de la reducción de los niveles de AurkA. Además, la epidermis de estos 
ratones presenta hiperplasia y un aumento en la proliferación de las células basales 
progenitoras. La localización apical de las proteínas Par3 y aPKC se pierde y la orientación 
de las divisiones de las células basales está alterada. Las células de la epidermis de estos 
ratones presentan alteraciones en la formación de las uniones adherentes y las uniones 
estrechas, la cual está íntimamente relacionada con la formación y el mantenimiento de la 
polaridad apico-basal. Asimismo, hemos descubierto que la localización de la forma activa 
de AurkA coincide con la distribución de las proteínas del complejo Par, tanto in vivo 
como in vitro, lo cual sugiere que AurkA está implicada en el mantenimiento de la 
polaridad celular en la epidermis. Tanto la eliminación del gen como la inhibición química 
de la proteína AurkA conducen a la pérdida de la correcta localización de las proteínas del 
complejo Par in vitro. La disminución de los niveles de AurkA en las células MDCK (un 
modelo celular ampliamente utilizado para estudiar la polaridad apico-basal) induce una 
pérdida de la proteína aPKC de la corteza celular y la aparición de malformaciones en 
cultivos epiteliales en tres dimensiones (3D) in vitro.  
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De forma global, nuestros resultados indican que la proteína AurkA está implicada en el 
mantenimiento de la polaridad apico-basal en la epidermis de mamíferos. Esta nueva 
función de AurkA extiende las implicaciones de esta proteína en el mantenimiento de la 
homeostasis de los tejidos más allá de su papel canónico en la regulación del ciclo celular. 
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1. Cell Polarity 
 
1.1. What is cell polarity? 
 
Cell polarity is a fundamental feature of almost all cell types. It refers to the existence of 
functionally and structurally distinct cellular compartments within cells, characterized by 
spatial differences of the cellular membrane, distinctive positioning of organelles, or the 
directionality of structural components, such as the intracellular cytoskeleton (Martin-
Belmonte and Perez-Moreno, 2012). Cell polarity is essential during morphogenesis, and 
for the maintenance of the homeostasis of adult tissues. It regulates a wide range of 
physiological processes including directed cell migration during development and wound 
repair, the acquisition and maintenance of cell shapes and tissue organization, polarized 
transport and secretion of molecules across cell layers, and the orientation of the plane of 
cell division (Thompson, 2013).  
The mechanisms that regulate cell polarity have been conserved throughout the 
eukaryotic kingdom. From unicellular cells such as yeast to multicellular organisms, 
including worms, flies and mammals, cell polarity proteins have been shown to exert 
parallel functions (Tepass, 2012; Macara and Mili, 2008). All these different models have 
since been utilized to study cell polarity and its involvement in the spatio-temporal 
regulation of diverse physiological events. A type of polarity that has been extensively 
studied in simple organisms is apical-basolateral polarity. This kind of cell polarity is 
characteristic of epithelial tissues, and it refers to the differential distribution of proteins 
and lipids into the apical and basolateral domains of the cell, and the positioning of 
organelles along the apical-basolateral axis. In epithelial tissues it is known to regulate 
morphogenesis, as well as maintenance of the tissue structure and integrity. However, our 
knowledge about the apical-basolateral polarity is only beginning to extend to the more 
complex, stratified epithelia.  
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1.2.   Apical-basolateral polarity in simple epithelia 
 
Apical-basolateral polarity in simple epithelia has been widely studied for many years in 
simple organisms such as Drosophila melanogaster, and it was not until the late 1970’s that it 
started to be explored in mammalian cells (Laprise and Tepass, 2011). Cells of the simple 
epithelium, a one-cell thick epithelial tissue, are columnar and present remarkable apical-
basolateral polarity features that allow the separation of the outer luminal space from 
internal compartments. Firstly, the apical surface of the epithelial cell’s membrane, which 
faces the luminal space, displays specialized membrane structures, such as microvilli and 
cilia. These structures are particularly important for the secretion, absorption and 
excretion of molecules and solutes across epithelial layers (Muthuswamy and Xue, 2012). 
The basal membrane attaches to the extracellular matrix (ECM), associating epithelia to 
their adjacent connective tissues, whereas through the lateral membrane, neighboring 
cells are held together sustaining the maintenance of cohesive epithelial layers. 
The spatiotemporal establishment of epithelial apical-basolateral polarity can be generally 
subdivided in four basic steps: 1) Epithelial cells receive an external signal arising from the 
ECM and/or neighboring cells, 2) A downstream signaling cascade of events involving 
the cell polarity machinery leads to the asymmetric compartmentalization of the cell 
membrane and organelles within the cell, 3) In parallel, cell polarity proteins are 
distributed to their appropriate domains; 4) Mitotic spindles orient along the established 
cell polarity axis (Figure 1)(Ahringer, 2003). 
 
1.2.1. Initiation of polarization: contact as an external signal 
The initial stages that lead to the establishment of apical-basolateral polarity involve the 
stimulation of epithelial cells by external cues. These signals are mainly mediated by the 
physical attachment of epithelial cells to the ECM, as well as the contact between 
neighboring cells. The initial contacts between cells lead in turn to the formation of cell-
cell junctions. Two types of cell-cell junctions, adherens junctions (AJs) and tight junctions 
(TJs), have been shown to play a fundamental role in the establishment, as well as the 
maintenance of apical-basolateral polarity. Their formation initiates polarized 
rearrangements of the cytoskeleton, and they facilitate the proper assortment of apical 
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and basolateral proteins to their specific domains (Perez-Moreno and Belmonte, 2012). 
(Figure 2A).  
 
 
Figure 1 Establishment of apical-basolateral polarity in simple epithelia 
	   	  
	  
	   18	  
 
Adherens junctions are essential for the development and physiology of epithelial tissues. 
In simple epithelia they are positioned below the TJs, and one of their main functions is 
to maintain the physical contact between epithelial cells (Meng and Takeichi, 2009) 
(Figure 2A). Two adhesive molecular units constitute AJs: the nectin-afadin complex and 
the classical cadherin-catenin complex (Niessen, 2007). The cadherin-catenin complex is 
composed of cadherin and catenin molecules (Harris and Peifer, 2004). Cadherins are 
calcium dependent proteins, thus the function and formation of the cadherin/complex 
strictly depends on the presence of extracellular calcium (Meng and Takeichi, 2009). 
During the initial stages of cellular interactions, both nectin/afadin and the calcium 
dependent cadherin/catenin complexes anchor to the actin cytoskeleton to strength the 
connection between neighboring cells. As more contacts are established, they extend the 
developing lateral membrane domain of epithelial cells, zipping the intercellular space 
between neighboring cells (Adams and Nelson, 1998; Vasioukhin and Fuchs, 2001). This 
process is closely linked to the distribution of proteins of the cell polarity machinery, 
which will be described in the next chapter. 
 
Tight junctions (Septate junctions in flies) are structures that distribute in the border 
between the apical and the lateral membrane domains. At this cellular location, TJ 
dynamically seal the membrane restraining the free diffusion of membrane proteins and 
lipids between the apical and lateral membrane. In addition, TJs function as a gate, 
regulating the passage of solutes of molecules through the intercellular space, thus 
maintaining the barrier function of epithelial layers. Tight junctions consist of an 
assortment of transmembrane proteins including the Junctional Adhesion Molecule 
(JAM), Claudins, and Occludins. These proteins associate through their cytoplasmic 
domain with scaffolding proteins, such as the zonula occludens proteins ZO-1, ZO-2, and 
ZO-3 (Niessen, 2007). Interestingly, at the initial stages of cadherin contact formation, the 
scaffolding protein ZO-1 is found associated to α-catenin to later distribute to TJs. This 
allows the establishment of TJs, and the maintenance of apical-basolateral polarity. The 
hierarchy of events regulated by these junctional complexes is therefore initially 
modulated by AJs. Of note, alterations in the functional activity, or loss of expression of 
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cadherins disturb TJs. However, the absence of either ZO-1 or ZO-2 has no effect on AJ 
functionality (Tunggal et al., 2005; Umeda et al., 2006). 
 
1.2.2. Establishment of asymmetry within the cell 
At nascent contacts, one of the first responses that lead to the establishment of cell 
polarity is the dynamic asymmetric rearrangement of the microtubule and actin 
cytoskeletons. Microtubules are formed by tubulin dimers that polymerize forming 
microtubule bundles. These structures have fundamental functions including the 
positioning of organelles within the cell, the formation of polarized structures such as cilia, 
and mitotic spindles, in addition to serve as tracks for transporting molecules. 
Microtubules growth from the microtubule organizing center (MTOC), which is usually 
the centrosome, towards the cell cortex. In addition, non-centrosomal microtubules are 
found organized along the apical-basal axis. In the context of apical-basolateral polarity, 
the asymmetric rearrangement of microtubules is like a road building that is necessary for 
vesicle trafficking and the proper targeting of newly synthesized polarity proteins to 
specific domains. Interestingly, microtubule cytoskeletal rearrangements and vesicular 
trafficking are not only necessary for the establishment of cell polarity, but they also seem 
to be regulated by cell polarity mechanisms as well. There is some evidence, for example, 
that polarity proteins are required for endocytic trafficking (Balklava et al., 2007). 
Moreover, it has been recently demonstrated that cadherins are required for the proper 
positioning of the centrosome and nucleus within the cell (Dupin et al., 2009). 
The actin cytoskeleton also plays a fundamental role in the establishment of apical-basal 
polarity. The initial contacts between cells are established by the dynamic contacts 
between filopodial extensions of neighboring cells (Adams and Nelson, 1998; Vasioukhin 
and Fuchs, 2001). At these membrane protrusions, the actin cytoskeleton is organized 
into actin cables. Once productive AJs linked to the actin cytoskeleton are established, the 
actin cytoskeleton branches and allows the formation of the actin cortical ring, via the 
spatiotemporal signaling mediated by small Rho GTPases (Rac1, Cdc42 and RhoA), and 
the activation of myosin-dependent mechanical forces (Mège et al., 2006). This in turn, 
extends the interphase of cell-adhesion and facilitates the assortment of cell polarity 
proteins to their developing specific domains (Tanos and Rodriguez-Boulan, 2008). 
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A)      B) 
Figure 2. Schematic representation of the differences between apical-basolateral polarity in A) 
simple epithelia and B) skin epidermis. 
 
1.2.3. Cell polarity complexes 
Many polarity proteins have been identified so far (Table 1). At the core of the polarity 
machinery are three polarity complexes: the apically located 1) Par and 2) Crumbs (CRB) 
complexes, and 3) the basolaterally located Scribble (SCRB) complex. 
 
Table1 Proteins of the cell polarity complexes  
Modified from: Macara, 2004 
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The Par complex consists of the Partition defective 3 (Par3) and Partition defective 6 
(Par6), which work together with atypical protein kinase C (aPKC) to regulate and 
maintain cell polarity (Chen and Zhang, 2013). The genes encoding for the three proteins 
were originally identified in genetic screens based in their requirement for the 
establishment of the anterior/posterior polarity of C. elegans zygotes. They were named 
‘Par’ for the observed partitioning defectiveness of zygotes deficient in these genes 
(Kemphues et al., 1988). Par3 (Bazooka in Drosophila) and Par6 are scaffolding proteins 
and they are able to bind to each other as well as many other proteins, whereas aPKC is a 
kinase protein. Par6 binds aPKC and inhibits its kinase activity, but also serves to recruit 
aPKC substrates, including Par3 (Nagai-Tamai et al., 2002). The interaction of aPKC 
and Par3 plays an essential role in the polarization of the epithelial cells (Nagai-Tamai et 
al., 2002). Par3 initially localizes at nascent nectin/afadin adhesion complexes to later 
dissociate from the lateral domain to distribute to the apical domain to associate to the 
TJs protein JAM, upon activation of the small RhoGTPase Rac1 (Martin-Belmonte and 
Perez-Moreno, 2012). In the apical domain, another important protein that cooperates 
with the Par complex is the small RhoGTPase Cdc42. The recruitment of Cdc42-
GTPase to the Par6/aPKC complex activates the kinase activity of aPKC (Joberty et al., 
2000). These interactions ensure that the Par complex is localized properly to the apical 
domain. Interestingly, Par3 is able to bind with its N-terminal domain to microtubules 
indicating a close relationship between the cellular cytoskeleton and the polarity protein 
complexes (Chen and Zhang, 2013). It has also been demonstrated that the Par complex 
can regulate actomyosin contractions during Drosophila epithelial polarization (David et al., 
2010)  
 
The Crumbs complex, which consists of the transmembrane protein Crb and the proteins 
PALS1 and PALS1-associated tight junction (PATJ), is required for the establishment of 
the apical membrane. Par3 and Crb proteins are somewhat redundant. Studies have 
shown that in tissues lacking Crb, Par3 can compensate for its loss to allow the proper 
polarization of epithelial cells (Thompson et al., 2013). 
 
The SCRIB complex consists of Dlg (Discs large), Scrib (Scribble) and Lgl (Lethal giant 
larvae), and they define the basolateral domain. Scribbled (Scrib) is a cadherin/catenin 
	   	  
	  
	   22	  
junction-localized protein (Navarro C et al., 2005). 
 
Polarity Complex interactions What do we know about the molecular journey of these 
proteins, upon polarization? The interaction of the cell with the extracellular matrix and 
neighboring cells leads to the recruitment of Par3 to primordial AJs as mentioned above. 
Further dissociation of Par3 from AJs is necessary to allow its redistribution to TJs, 
allowing the recruitment of TJs-associated proteins and the establishment of mature TJs. 
This dissociation requires the phosphorylation of Par3 by aPKC, and the two, together 
with Par6 redistribute to the apical domain.  
At the same time, SCRIB promotes the basolateral membrane identity. The Par 
Complex has an antagonistic reaction with the basolateral proteins, including Par 1 and 
SCRIB complex proteins, which ensures that the proteins of the two domains do not mix. 
Some biochemical studies have provided some clues as to how apical proteins, through 
their antagonistic interactions, can be brought to the apical domain. For example, Par1 is 
known to phosphorylate the oligomerization domain, lipid binding-domain, and aPKC 
binding domain of Par3, driving Par3 to associate with the apical membrane by 
oligomerizing and interacting with aPKC (Izumi et al., 1998). However, it remains 
unclear how apical determinants restrict Par1 to the basolateral domain. Overexpression 
of aPKC or knock-down of Lgl enlarges the apical domain at the expense of lateral 
domain, whereas loss of aPKC activity or overexpression of Lgl reduces the apical 
domain (Humbert et al., 2003). Overall, these studies suggest that the interaction between 
the apical and basolateral proteins complexes at the cortex leads to mutual exclusion to 
sustain the identity of the plasma membrane domains.  
Interestingly, studies in yeast have also shown that the polarized localization of these 
protein complexes is not only achieved through antagonistic interactions, but also 
through a simple positive-feedback loop in which the rate of Cdc42 recruitment to the 
bud site depends on the concentration of Cdc42 already residing at this location (Sardon 
et al., 2010). However, this phenomenon has not been yet demonstrated in mammalian 
tissues. 
The intimate connection between polarity complexes to AJs and TJs highlights its 
functional codependence. Namely, it has been observed that the disruption of junctions 
and their components leads to loss of cell polarity. For example, in mouse keratinocytes, 
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loss of ECAD and PCAD leads to the loss of the polarized localization of aPKC and Par3 
(Tinkle et al., 2008). Conversely, there is evidence that the disruption of polarity proteins 
can lead to problems in junction formation and/or stability, suggesting that apical-
basolateral polarity is important for the cellular functions of these adhesion complexes, 
such as junction formation. It has been shown in the Drosophila epithelium, that the 
recruitment of ECAD into apical junctions requires Bazooka (Par3) (Harris and Peifer, 
2004). Similarly, in the skin one study showed that Par3 controls the assembly of tight 
junctions through the Rac exchange factor Tiam1 (Chen and Macara, 2005). In 
summary, the complexity of cell polarity lies in the great number of interweaving 
interactions among all it’s components, including junctions, cytoskeleton, and cell polarity 
complexes. 
 
1.2.4. Spindle orientation    
Natural world is spawned by incredible cell diversity. Through their development, 
multicellular organisms must give rise to different types of tissues, and this process implies 
that mother cells give rise to one daughter differentiated cell and another that maintains 
its progenitor characteristics. This asymmetric cell division is achieved through a precisely 
oriented cell division. This process is defined through two, mutually coupled events: 1) 
establishment of polarity, which implies unequal distribution of polarity proteins; and 2) 
alignment of the mitotic spindle with the respect to the polarity axis (McCaffrey and 
Macara, 2011). Thus, for asymmetric cell division to occur, cells have to rotate their 
mitotic spindles allowing the differential distribution of cell fate determinants between the 
mother and the differentiating cell. Oriented cell divisions are not only important during 
development, but also for the maintenance of the homeostasis of adult tissues. For 
example, in the brain during the division of neuroblasts, mitotic spindles must align with 
the established posterior/anterior polarity axis, ensuring the proper asymmetric cell 
division. Therefore, cell fate can be the result of cell polarity. The fundamental roles of 
asymmetric cell divisions in the specification of cell fate have already been determined in 
several mammalian tissues including the brain, the mammary epithelia, the lung, the 
intestine and the epidermis (Martin-Belmonte and Perez-Moreno, 2012). Genetic 
identification of the spindle orientation regulators occurred nearly two decades ago and 
the list of proteins required for proper spindle orientation has grown tremendously. 
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Among these regulators are the cell polarity complexes. For example, it was shown in C. 
elegans that loss of Par3 leads to aberrant spindle orientation, during the asymmetric 
division of the first embryonic cleavage (Cheng et al., 1995; Etemad-Moghadam et al., 
1995). In mammals, loss of Par3 leads to loss of asymmetric cell divisions, leading to an 
increase in symmetric divisions and the expansion of tumor cells in the epidermis or 
mammary epithelia (McCaffrey and Macara, 2009; Niessen et al., 2012). In addition, the 
loss of tumor suppressor genes, such as p53, or APC has been correlated with the loss of 
oriented cell divisions and the proliferation of tumor cells in the mammary epithelia 
(Cicalese et al., 2009), or in the gut (Quyn AJ et al., 2010). Overall, these results highlight 
the relevance of studying the mechanisms that control epithelial cell polarity during 
development and disease. 
 
 
2.   The Skin  
 
2.1 Organization of the skin 
 
The largest organ of our body, the skin, has evolved to play a fundamental role in the 
maintenance of the body’s homeostasis. It offers protection, sensation, thermoregulation, 
and absorption. While protecting the body, skin is exposed to many stresses, which can 
lead to damage and disease, such as skin cancers (Fuchs and Horsley, 2008). 
The skin consists of: epidermis (an ectoderm-derived epithelial tissue), the underlying 
dermis (of mesodermal origin, composed of mesenchymal cells and ECM), subcutaneous 
fat, and the epithelial appendages, such as hair follicles and sebaceous glands (Fuchs, 
2007). The epidermis, which forms the outermost layer of the skin, is a self-renewing, 
stratified epithelia that consist of several layers. The basal layer is the proliferative one, 
which gives rise to the upper, differentiated postmitotic layers of the epidermis via a fine-
tuned terminal differentiation program: spinous (Stratum spinosum); granular (Stratum 
granulosum), and the outermost, cornified layer (Stratum corneum) (Fuchs and Horsley, 2008). 
The maintenance of this epithelial structure in the skin is essential for tissue homeostasis, 
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and it is greatly dependent on functional cellular junctions and the polarized organization 
of the cells across the skin tissue as a whole.  
 
2.2 Apical-basolateral polarity in the epidermis 
 
The establishment and maintenance of apical-basolateral cell polarity in the epidermis is 
not only important for tissue architecture, but also for the regulation of oriented cell 
divisions, and the formation of a functional protective barrier. Like simple epithelia, the 
cells of the basal progenitor layer of the epidermis present intrinsic apical-basolateral 
polarity, and many polarity players found in simple epithelia are also found in the skin 
epithelium. However, when it comes to apical-basolateral polarity there are many 
differences between these two types of epithelia, since the stratified epidermis presents a 
tissue level of polarity, which makes polarity in tissues like skin more complicated to 
understand. First, unlike simple epithelia, where TJs are positioned in the border of the 
apical lateral boundaries of the two membrane domains within the cells, in stratified 
epithelia TJs are only present in the uppermost granular layer, also performing their 
specialized barrier functions (Niessen, 2007)(Fig 2B). Secondly, the Par complex proteins 
are expressed in the apical domain of basal progenitor cells, but distribute around the 
whole cell cortex of suprabasal-differentiated cells (Harris and Peifer, 2004)(Figure 2B). 
This unique design of polarity in stratified epithelia is still poorly understood, and further 
works is needed to understand the mechanisms involved in achieving such specialized 
level of polarization. 
Further, there is some evidence indicating that in the skin epidermis, like in the simple 
epithelia, the proteins of the AJs and TJs can regulate the distribution and function of the 
polarity complexes (Harris and Peifer, 2004). Cadherin-deficient epidermis displays 
defective localization of Par3, aPKC, and Scribble. Conditional ablation of alpha-catenin 
(?-cat), a component of adherens junction, in the epidermis induces hyperplasia and loss 
of polarity (Vasioukhin and Fuchs, 2001; Lechler and Fuchs, 2005). However, it is 
particularly puzzling to consider this link since AJs of the basal layer of the epidermis, 
unlike in the simple epithelia, are unpolarized and distribute around the whole cell cortex. 
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Despite the differences between simple epithelial cells and the segregation of the polarity 
complexes and cell junctions across the apical axis of the whole epidermis, several 
functional parallels are found in the regulation and codependence of cell adhesion, and 
cell polarity events. There is some evidence that Par complex members can affect 
junctional stability in skin. It has been shown that aPKC activity is necessary for the 
formation of TJs in stratifying keratinocytes in vitro (Denning, 2007). In recent years both 
Par complexes and aPKC have also been implicated in the maintenance of the polarized 
architecture of skin and alterations in the expression of aPKC leads to barrier function 
defects (Denning, 2007; Niessen et al., 2012). 
 
2.2.1  Apical-basolateral polarity and asymmetric cell division in     
   skin 
Besides the Par complex, Inscuteable and LGN are other two polarity proteins that are 
conserved, and in skin epithelia are found colocalizing apically with Par3, only during 
mitosis (Lechler and Fuchs, 2005). This Par3/Insc/LGN complex is very important for 
the recruitment of the effectors of spindle orientation-molecules that can interact with and 
generate force on the mitotic spindle. These effector proteins include NuMA and the cell 
motor complex formed by dynein/dynactin. NuMA is a microtubule binding protein that 
localized to both spindle poles and the apical cortex in asymmetrically dividing skin 
epithelial cells (Williams et al., 2011). Symmetric and asymmetric cell divisions (SCD and 
ACD) are key to the balanced proliferation and differentiation in the epidermis. Several 
studies have shown that apical-basolateral polarity, together with its complexes and 
junctions, can regulate the orientation of cell divisions, thus affecting ACD and SCD. 
Induction of INSC induces perpendicular cell division orientation, shortly after induction, 
and 3 days later, the effect is opposite (Poulson and Lechler, 2010). Knock down of LGN 
or NuMA leads to the bias towards parallel cell division (Williams et al., 2011). 
Interestingly, this process seems to regulate the Notch dependent differentiation of basal 
progenitor cells (Williams et al., 2011). It has been also shown that the loss of adhesive 
cues, such as integrin beta1 or ?-cat in mouse epidermis results in random spindle 
orientations (Lechler and Fuchs, 2005).  
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3.   Polarity and cancer 
 
There is a growing amount of data showing that the localization or the expression of 
some of the polarity proteins is changed in many human cancers (McCaffrey et al., 2012). 
For example, Par complex proteins are often overexpressed in many human cancers 
(Table 2). However, our understanding of the role of polarity in cancer in mammals is still 
poor. It has been suggested that aPKC could be an oncoprotein, since its expression is 
usually elevated in human epithelial cancers, including lung, liver, pancreas, ovarian, 
prostate, and colon (Martin-Belmonte and Perez-Moreno, 2012). One study showed that 
aPKC functions downstream of RAS signaling and upstream of Rac1GTPase, in lung 
and colon carcinogenesis. LKB1 (Par4 in Drosophila), is a serine/threonine kinase that also 
regulates cell growth and polarity in metazoans, whose mutation has been also directly 
associated with human cancers (Jansen et al., 2009). Epidermal inactivation of LKB1 
predisposes mice to non-melanoma skin cancer, thus providing direct evidence that 
LKB1 serves as a cell-autonomous tumor suppressor in the skin (Gurumurthy et al., 2008). 
Interestingly, LKB is also linked to metabolic pathways and AMPK signaling.  
SCRIB has also been implicated in playing a tumor suppressor role. It has been 
demonstrated recently, in vivo and in vitro, that loss of SCRIB decreases apoptosis and 
increases cellular trasformation via the MYC signaling pathway (Wu et al., 2012). 
Another study has demonstrated that silencing of Par3 in the mammary glands reduced 
the latency of tumors expressing oncogenic Notch or Ras (Cafely et al., 2012). Par3 
depletion was associated with induction of MMP9, destruction of the extracellular matrix, 
and invasion. This was mediated by aPKC-dependent JAK/Stat3 activation. This is 
important because Par3 is significantly reduced in human breast cancers, which correlates 
with active aPKC. Ablation of Par3 in the epidermis inhibits formation and growth of 
papillomas. However, those mice are predisposed to the formation of keratocanthomas 
(Iden et al., 2012). 
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Table 2. Alterations of PAR complex  proteins in human cancers (modified from Martin 
Belmonte and Perez-Moreno, 2012) 
 
A way in which defects in apical-basolateral proteins can act as a tumor initiation is by 
deregulating spindle orientation, and thus the balance between symmetric and 
asymmetric cell division. Prior studies in Drosophila have shown that switching from ACD 
to SCD promotes unrestricted growth and tumor formation (Januschke and Gonzalez, 
2008). In the context of cancer initiation, alterations in spindle orientation and 
asymmetric cell division have been implicated in the acquisition of tumorigenic 
characteristics (Quyn et al., 2010). Using lineage-tracing approaches this study 
demonstrate a clear correlation between spindle orientation and the occurrence of 
asymmetric cell divisions. Furthermore, this correlated with an increase in perpendicular 
spindle orientations and reductions in ACDs in the pre-cancerogenic gut of the APC 
deficient mouse model (Quyn et al., 2010). Similarly, the loss of the tumor suppressor 
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gene p53 has also been associated with an increase in SCD of mammary carcinoma cells 
(Cicalese et al., 2009). As another example, the Lgl knock-out (KO) mice present 
randomized cell divisions in neural progenitors, causing severe brain dysplasia 
(Klezovitch et al., 2004).  
One of the most direct evidences making the link between cancer and polarity is provided 
in the study showing that the TGFβ receptor directly interacts with Par6 and 
phosphorylates Par6 (Ozdamar et al., 2005). This phosphorylation event is necessary for 
the TGFβ-dependent Epithelial to Mesenchymal Transition (EMT) in mammary gland 
epithelial cells. However, our understanding of the molecular links between cell polarity 
proteins and cancer initiation and progression is still very poor.  
 
 
4. Aurora kinase A  
 
1.1 A mitotic protein that functions beyond mitosis 
 
Aurora Kinase A (AurkA) is also known as serine/threonine kinase 15 (STK15), 
serine/threonine kinase 6 (STK6), breast tumor amplified kinase (BTAK), and Aur-
related kinase 1 (ARK1). As the names indicate, AurkA is a serine/threonine kinase that 
is part of the Aurora /IPL1-related kinase family, that comprises of AurkA, AurkB and 
AurkC. It’s a 403- amino acid protein with a canonical kinase domain and it is mostly 
known for its role during mitosis, although new non-mitotic roles of the protein are now 
emerging, including the control of cell polarity (Nikonova et al., 2013). 
 
4.1.1.  Mitotic role of AurkA 
During mitosis AurkA plays a role in centrosome maturation, timing of mitotic entry, and 
the construction and control of bipolar spindle. It begins to accumulate significantly at the 
centrosomes in the S phase and is activated at the transition between the G2 and M 
phases. This accumulation of AurkA at the centrosome allows for the nucleation of the 
microtubules that form the mitotic spindle. In this way AurkA is necessary for the trigger 
of the mitotic entry. Once activated, AurkA moves down the spindle to the midzone of 
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the plane of division, after which it facilitates chromatin separation and cytokinesis (Fu et 
al., 2007).   
In a recent computational study integrating different sources of biological information, a 
list of 90 AurkA substrates was generated (Sardon et al., 2010). Some of these substrates 
activate AurkA and others are activated by AurkA. The activation and degradation of 
AurkA is regulated spatio-temporally by many proteins. One of the major events is the 
regulation of AurkA via phosphorylation. This can be triggered by several proteins, which 
in turn can then lead to the auto-phosphorylation of AurkA. The most studied AurkA 
regulatory proteins are TPX2, Ajuba, NEDD9 and BORA (Vader and Lens, 2008). At 
the breakdown of the nuclear envelope, TPX2 is released from an inhibitory complex and 
binds to AurkA. This binding leads to a conformational change of AurkA that allows the 
access for AurkA substrates. This interaction also helps AurkA to be targeted to the 
mitotic spindle. Regarding other interactions, it has been shown that the association of 
AurkA with Ajuba is important for the activation of cyclinB/CDK1 complex and the 
mitotic commitment (Vader and Lens, 2008). Other substrates of AurkA include 
BRACA-1, p53, Eg5, CDC25B (Kollareddy et al, 2008). 
 
4.1.2. Non-mitotic roles of AurkA 
Recently, several lines of evidence have emerged suggesting that AurkA functions beyond 
its fundamental role in mitosis. Particularly, there are studies showing that AurkA is 
involved in microtubule dynamics, cell migration, disassembly of cilia, and cell polarity. 
Chemical inhibition of AurkA, in mammalian cells in interphase, leads to the abrogation 
of microtubule dynamics (Lorenzo et al., 2009), suggesting that a pool of AurkA is active 
in non-centrosomal compartments. It has also been demonstrated that AurkA plays a role 
in neurite elongation and migration where the interaction between NEDD9 and AurkA is 
responsible for the effect (Mori et al., 2009). In the unicellular organism Chlamydomonas it 
has been shown that the AurkA ortholog CALK regulate flagellar length (Pugacheva et al., 
2007). Interestingly, in a parallel way in mammalian cells, AurkA via interaction with 
NEDD9, function in the basal body of the cilium in non-cycling G0/G1 cells to promote 
ciliary reabsobtion (Pugacheva et al., 2007). 
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4.1.3.    The emerging link between AurkA and polarity 
In 2002, Berdnik and Knoblich showed that AurkA is required for centrosome 
maturation and actin-dependent asymmetric protein localization. In 2008, Wirtz-Peitz et. 
al demonstrated that in the Drosophila neuroblast, AurkA phosphorylates the Par complex 
linking cell polarity with asymmetric cell division. In this pathway, AurkA plays a role in 
phosphorylating Par6, which leads to the activation of aPKC and replacement of Lgl by 
the Bazooka protein, within the Par complex. This is required for the release and 
exclusion of Lgl from the cortex of one of the dividing cells to the other, in addition to the 
proper localization of the protein NuMa. Another evidence that has linked AurkA with 
cell polarity is the identification of the existence of aPKC-AurkA-NDEL1 pathway, which 
is crucial for the regulation of microtubule organization during neurite extension (Mori et 
al., 2009). 
There are several studies describing AurkA’s involvement in symmetric and asymmetric 
cell division. A very recent work shows that AurkA regulates mammary epithelial cell fate 
by regulating spindle orientation in a Notch-dependent manner (Regan et al., 2013). 
Another study showed that the complete deficiency of AurkA in epidermal cells during 
skin development leads to alterations in cell division, and thus stratification (Torchia  et al. 
2013). Although this was mainly attributed to the mitotic roles of AurkA, stratification, 
although aberrant, still occurred suggesting a possible involvement of AurkA in the 
balance of symmetric and asymmetric cell divisions of epidermal progenitor cells. 
 
 
4.2. AurkA and cancer 
 
Many solid tumors, including colorectal, breast, ovarian, prostate, neuroblastoma, and 
cervical cancers present an increase in AurkA levels. AurkA is situated on chromosome 
20q13.2, a locus that is frequently amplified in solid tumors (Vader and Lens, 2008). 
However, in some cases AurkA is increased in the absence of the chromosomal 
rearrangements. Overexpression of AurkA transforms NIH3T3 cells, and when these cells 
are injected into nude mice, they grow tumors (Fu et al., 2007). AurkA is transcriptionally 
regulated by several transcription factors, including STAT5a, estrogen/GATA3, HIF1. 
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In cancers, some of these transcription factors are misregulated, leading to the aberrant 
levels of AurkA (Ochi et al., 2009). The result of AurkA overexpression is the presence of 
multiple centrosomes, which leads to multiple spindles, increased resistance to apoptosis 
and deficient cell cycle checkpoint. Interestingly, however, the overexpression of AurkA is 
not sufficient to induce tumorigenesis. But in a p53 deficient background, in a mouse 
model of mammary carcinogenesis, the overexpression of AurkA was able to induce 
tumorigenesis (Wu et al., 2012). Normally, AurkA overexpression leads to the spindle 
check-point activation or clearance of cells by apoptosis. However, loss of p53 eliminates 
this check-point, leading to aberrant cell divisions and genomic instability. Thus the 
proposed model is that AurkA overexpression causes centrosomal amplification, which 
would normally lead to the check-point activation and apoptosis. However, when cells 
lose p53, they are overriding checkpoints and continuing with the cell division, which can 
lead to aneuploidy and cancer (Wu et al., 2012).   
For these reasons, AurkA has attracted a lot of attention as a potential therapeutic target. 
The scientific literature tends to consider elevated levels of AurkA as a predictive value of 
aggressiveness of cancers, although there is literature that contradicts this dogma. As of 
2012 there are 9 compounds that target AurkA that have made it through preclinical 
testing into phase I and II (Ochi et al., 2009). The most promising one so far has been 
MLN8237 (alisertib), which has shown to have some effect in combination with other 
drugs .  
Interestingly, in 2008 a study made by Lu et al. was published demonstrating that the 
AurkA-/+genetic mouse model develops spontaneous tumors. Indeed the heterozygous 
mice presented 3-fold higher incidence of tumors. Tumors found were in various organs, 
including thymus, lung, liver and lymph node. Most tumors were lymphoma that invaded 
the lung.  
It is understood that a way in which AurkA contributes to the tumor development is 
through genomic instability. However, lately, new roles or AurkA are being discovered, 
suggesting that there may be additional pathways through which AurkA may plays a role 
in cancer. 
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Apical-basolateral polarity in epithelial tissues is fundamental during morphogenesis for 
the acquisition and maintenance of proper tissue architecture, polarized cell movements 
and oriented cell divisions. These important roles are also sustained in adult tissues 
preserving their physiological balance. Alterations in the functional activity of the proteins 
that partake in the cell polarity machinery have been associated with disease, including 
the acquisition of tumorigenic characteristics. Despite the relevance of these events, little 
is known about the mechanisms that regulate cell polarity in stratified epithelia, such as 
the skin. Using mouse genetic models and cell culture studies, the main goal of this thesis 
was to characterize the involvement of Aurora kinase A, a mitotic protein, in the 
regulation of the establishment and maintenance of apical-basolateral polarity of 
epidermal cells. 
 
1. Characterize the epidermis of the K14CreERT2; AurkA∆ep/+ and K14CreERT2; 
AurkA∆ep/∆ep mice during skin development. 
2. Investigate the involvement of AurkA in the regulation of the acquisition and 
maintenance of the apical-basolateral polarity properties of epidermal cells, both in 
vivo and in vitro. 	  	  	  	  	  	  	  	  	  	  	  	  
	   	  
	  
	  
	  	  	  	  	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   	  
	  
	   39	  
 
 
 
 
Objetivos
	   	  
	  
	  
	   	  
	  
	   41	  
En los tejidos epiteliales la polaridad apico-basal es fundamental durante el desarrollo 
embrionario para la adquisición y el mantenimiento de una arquitectura tisular correcta, el 
movimiento polarizado de células y la orientación de las divisiones celulares. Estas 
funciones tan cruciales también preservan el balance fisiológico de los tejidos adultos. Las 
alteraciones en la actividad funcional de las proteínas que regulan la polaridad celular están 
asociadas con diversas enfermedades, entre ellas la adquisición de características tumorales. 
A pesar de la relevancia de estas proteínas, no se conocen bien los mecanismos que 
regulan la polaridad celular en tejidos epiteliales estratificados, como la epidermis de la piel. 
Utilizando modelos de ratón modificados genéticamente y cultivos celulares, el objetivo 
principal de esta tesis es caracterizar el papel de Aurora Kinasa A, una proteína del ciclo 
celular, en la regulación de la formación y el mantenimiento de la polaridad apico-basal en 
células de la epidermis. 
1. Caracterizar la epidermis de ratones K14CreERT2; AurkAΔep/+ y K14CreERT2; 
AurkAΔep/Δep durante el desarrollo embrionario. 
2. Investigar el papel de AurkA en la regulación de la formación y el mantenimiento 
de la polaridad apico-basal en células de la epidermis, in vivo e in vitro.
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Methods
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1. Mice 
 
• Mouse strains, mouse treatments, and embryo collection 
All the animal experiments performed in this study, were previously approved by the 
Animal Experimental Ethics Committee of the Instituto de Salud Carlos III (Madrid, 
Spain). K14CreERT2; AurkA lox/lox mice were kindly provided by the laboratory of 
Malumbres M. at CNIO. All matings were set at night and the presence of vaginal plugs 
was corroborated the following morning, which indicated day E0.5 of pregnancy. 
Starting on the E11.5 day of development, the in vivo recombination of the floxed AurkA 
gene was induced by the intraperitoneal administration of 3mg of tamoxifen (Sigma, St. 
Louis), dissolved in 100 µl of sunflower oil. Daily injections were maintained until the day 
of the collection of the embryos (E14.5, E15.5, E16.5, E17.5, E18.5). Alternatively, in a 
different set of experiments, two daily injections were given prior to the collection of the 
embryos. For the ablation of AurkA in adult mice, 5 daily injections of the same dosage of 
tamoxifen were administered intraperitoneally to mice before their sacrifice.  
For the AurkA ablation in the adult mice, 5 daily tamoxifen injections of 3mg were 
sufficient. 
The presence of heterozygous, homozygous floxed alleles, or deleted alleles was detected 
by PCR using the following primers:  
- Primers that amplify the deletion allele (274 bp product) 
Fw  CAGAGTCTAAGTCGAGATATCACCTGAGGGTTGA 
Rw  GATGGAAACCCTGAGCACCTGTGAAAC 
- Primers to screen for the presence of 2 products: 467 bp = wildtype, 594 bp = floxed 
allele 
Fw   CCTGTGAGTTGGAAAGGGACATGGCTG 
Rw  CCACCACGAAGGCAGTGTTCAATCCTAAA 
 
K14CreERT2; AurkAlox/lox mice were crossed to Rosa26LacZ mice, in order to generate 
a reporter mouse model for the activity of Cre, upon tamoxifen administration.  
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For the performance of bromodeoxyuridine (BrdU) staining to monitor cell proliferation 
in vivo, pregnant females were injected with 2 mg of BrdU (Sigma, St. Louis), dissolved in 
100µl of PBS, 3 h before the embryo collection.  
 
• Epidermal Permeability Barrier (EPB)  
Unfixed, untreated, freshly isolated embryos were rinsed in PBS. They were then 
submerged into 70% ethanol containing 0.01 mg of bromophenol-blue. They were kept 
for one hour at 37 °C, then rinsed well and analyzed. 
 
• Histology and Immunostaining  
For BrdU, X-gal, and Immunofluorescence (IF) stainings, unfixed embryos were 
embedded in optimal cutting temperature compound (OCT) and kept at -80C. Frozen 
embryos were then sectioned in the cryostat to obtain 7 µm sagital sections. For IF 
analyses, sections were first fixed with 4% paraformaldehyde for 10 min at room 
temperature (RT), washed with 1X PBS for 5 min, then blocked with the blocking buffer 
(0.3% Triton, 1% BSA, 1 % Gelatin, 5% normal goat serum, 5% normal donkey serum 
in 1X PBS) for 30 min. The incubation of primary antibodies was performed following 
the manufacturer’s instructions.  
For X-gal stainings, sections were fixed with the fixative solution (0.2% glutaraldehyde, 5 
mM EGTA pH 8.0 in water), 2 mM MgCl2 and 0.1 M Sodium phosphate buffer pH 7.2) 
for 5-10 min at RT, then washed twice for 20-30 min at room temperature with a 
washing solution (0.1M Sodium phosphate buffer pH 7.2, 2 mM MgCl2, 0.1% Sodium 
deoxycholate, 0.02% Nonidet P40 in water). Slides were then transferred to a pre-
warmed staining solution containing 1mg/ml X-gal (Promega, Fitchburg), 5mM 
K3Fe(CN)6, 5mM K4Fe(CN)6-3 H2O in washing solution. The slides were left at 37°C 
overnight, then washed three times with the washing solution, with mild agitation, at 
room temperature, and then four times with PBS. Slides were then stained with DAPI, 
dried and mounted.  
For BrdU stainings, after fixation in 4% PFA in PBS, sections were washed well in PBS 
and incubated in 1N HCl at 37°C for 30 min. Then, the slides were blocked, and 
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incubated with primary and secondary antibody according to the manufacturer’s 
instructions.  
For Hematoxylin & Eosin (H&E) stainings and AurkA immunohistochemical analyses, 
embryos were fixed in formalin and embedded in paraffin. A standard protocol of 
deparafinization was followed and the sections were stained with AurkA antibodies 
following the protocol described above. For H&E stainings, after fixation in PFA, slides 
were incubated consecutively with hematoxylin and eosin for 5 min, with 3 PBS washes 
in between. Slides were dried and mounted for all the analyses.  
 
 
       2. Culture of mouse primary keratinocytes and  
          cell treatments 
 
• Isolation and culture of primary keratinocytes  
Primary keratinocytes were isolated from the tail of adult K14CreERT2; AurkA lox/lox or 
K14CreERT2; AurkA lox/+ mice. In brief, tail skin was incubated in dispase (Sigma, St. 
Louis) and trypsin (Gibco, Aucklan). After filtering cell suspensions through 40 µm cell 
strainers, cells were cultured in Low Calcium Medium – LC (0.05mM < Ca++). They 
were cultured on a plate of Ca++-free growing fibroblasts pretreated with mitomycin C 
(feeder cells). They were passaged twice onto plates with mitomycin C-treated feeders, 
until they became feeder-independent. Double E-cadherin KO; P-cadherin shRNA cells, 
as well as control cells, were kindly provided by E. Fuchs, Rockefeller University, NY. 
 
• Treatments and transfections of primary keratinocytes 
To ablate AurkA, 70% confluent cells were treated with 600 nM 4-OH Tamoxifen 
(Sigma, St. Louis) for 24 h. The absence of AurkA was tested by immunoblot and PCR. 
For the inhibition of phospho AurkA, the MLN8237-Alisertib inhibitor (Selleckchem, 
Houston) was administered to the cells, at a concentration of 15 µM.  Almost 100 % of 
cells exhibited the loss of the pAurkA IF signal after 24 h incubation. Due to the 
reversibility of the binding of the molecule, the treatment with the inhibitor was 
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performed again after 24 h. The PKC ? Pseudosubstrate (Millipore, Darmstardt) was 
used at a final concentration of 1 µM. Cells were analyzed 12 h after the treatment.  
 
Primary mouse keratinocytes were transfected with a plasmid expressing AurkA-GFP 
(kindly provided by the laboratory of M. Malumbres, CNIO, Madrid), using the X-
tremeGENE DNA Transfection reagent (Roche, Mannheim) according to the 
manufacturer’s instructions.  
 
• Cytoochip and migration assay  
24 h after addition of tamoxifen in culture, cells were trypsinized and plated onto the 
umbrella-shaped, fibronectin coated commercial micropatterns (CYTOO, Grenoble), 
using the protocol provided by the manufacturer, with slight modifications. In brief, 
cytoochips were placed in a well of a 6-well plate. 60,000 cells were seeded per cytoochip 
and 4 ml of LC media were added to each well. Cells were allowed to attach to the 
Cytoochips for 9 h, the coverslips were gently washed with 1 X PBS, fixed and 
immunostained with an antibody that recognizes the Golgi marker (GM130), and DAPI, 
according to the protocol described above. For migration assays, cells were plated on 
coverslips, once attached, the in vitro recombination of AurkA was performed by the 
addition of tamoxifen. 24 h later, two small scratches were made with a small pipette tip 
on the confluent monolayer of cells. 9 h later, cells were fixed and stained for GM130 and 
DAPI.  
 
• Calcium switch assay 
Keratinocytes were grown to full confluency in LC medium, and then their media was 
replaced for a media containing 1.8 mM Ca++ (Normal Calcium media – NC), to induce 
the formation of cell junctions. Cells were washed with PBS, fixed and stained as 
indicated above at different time points to perform kinetic analyses of the formation of 
cell-cell junctions. 
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• Immunofluorescence 
Primary mouse keratinocytes plated on coverslips were fixed with 4% PFA for 5 min, 
washed with PBS and blocked using the blocking solution (described above). Cells were 
incubated with primary antibodies according to the manufacturer’s instructions, followed 
by incubation with fluorescence conjugated secondary antibodies. 
 
• Immunoblotting 
For analysis of total protein levels by immunoblotting, cells were lysed in RIPA buffer 
containing: 50 mM Tris-HCl pH 7.4, 1% NP-40, 0.2% sodium deoxycholate, 150 mM 
NaCl, 1 mM EDTA and 0.2% SDS and proteinase inhibitors. Proteins were subjected to 
SDS-PAGE electrophoresis under reduced conditions, and transferred to nitrocellulose 
membranes. Primary antibodies were used to perform the immunoblot analyses 
according to the manufacturers’ instructions. Immunoblots were developed using the 
ECL system (Invitrogen).  
 
 
3.  MDCK culture and treatments 
 
• MDCK culture  
MDCK II cells, kindly provided by the laboratory of Martin-Belmonte F. at CBM, 
Madrid, were cultured in MEM media (Life Technologies, Carlsbad), containing 
GlutaMAX (Gibco invitrogen, Carlbad), 5 % FBS and Pen/Strep.  
 
• MDCK treatments, electroporation and transfection 
The AurkA inhibitor MLN8237-Alisertib (Selleckchem, Houston) described previously 
was also administered to MDCK cells, at a concentration of 20 µM.  
For the AurkA knockdown experiments, MDCK cells were electroporated using the 
NEON transfection system (Invitrogen, Carlbad), or the X-tremeGENE transfection 
reagent according to the manufacturer’s protocol. A cocktail of two AurkA siRNAs with 
the following sequences was used: AurkA1: 5'-AUGCCCUGUCUUACUGUCA-3' ; 
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AurkA2: 5'-AACGUGUUCUGGUGACUCA-3' (Life Technologies, Carlsbad). The 
ON-TARGETplus Non-targeting siRNA (Thermo Scientific, Waltham) was used as a 
negative control. One million cells were transfected with 1 µg of each siRNA. 48 h after 
transfection, the reduction on the expression of AurkA was confirmed by IF analysis and 
immunoblot. 
 
• MDCK cyst formation on Matrigel 
Half a million cells were plated in one well of a 6-well plate. A day after, cells were 
washed with PBS for 15 min, trypsinized with 1 ml of trypsin and later neutralized with 1 
ml of media, without centrifugation. In parallel, 8-well chamber slides were covered with 
8 µl of Matrigel (BD, Franklin Lakes) and dried for 10 min. 2,500 cells were then seeded 
per well and grew in 250 µl of media containing 2  % Matrigel. 4 days later, the specific 
AurkA inhibitor was added to the media. After 20 h of incubation, cells were fixed and 
immunostained using 0.1% SDS in PBS to permeabilize the cells and incubated for 3 h 
with primary antibodies. 
 
 
•    MDCK Calcium switch  
MDCK cells were grown in MEM media until confluency. Cells were washed 3 times in 
PBS for 5 min. Then MEM media without Calcium, supplemented with 5 % of Ca++- 
chelated FBS was added to cells to promote the loss of cell-cell adhesion. 20 h later this 
medium was replaced by standard MEM media containing Ca++ to induce the formation 
of cell-cell contacts.  
 
• Immunofluorescence  
MDCK cells plated on the coverslips were fixed with -20 ºC methanol for 2 min, washed 
with PBS and blocked using the blocking solution described above. MDCK cells were 
incubated with primary antibodies according to the manufacturer’s instructions, followed 
by incubation with fluorescencent conjugated secondary antibodies. Images were 
acquired using a Nikon fluorescent microscope, using the oil immersion objectives 40 X 
or 63 X. 
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4.   Antibodies 
PKC ?  rabbit antibody (sc-216, clone C-20, Santa Cruz), 1:500, pAurkA rabbit 
antibody (AB83968, Abcam, Cambridge), 1:500 dilution; AurkA mouse monoclonal 
antibody for IF (AB13824, Abcam, Cambridge), 1:300 dilution; AurkA mouse antibody 
for IHC (610938, BD Franklin Lakes); BrdU rat antibody (6326, Abcam, Cambridge), 
1:1000 dilution; β-catenin mouse antibody (C7207, Sigma, St. Louis), 1:500; E-cadherin 
rat antibody (12-1900, Invitrogen, Carlsbad); Filaggrin rabbit antibody (PRB-417B, 
ATOM, Barcelona), 1:200 dilution; GM130 mouse (610822, BD, Franklin Lakes) 1:500; 
pHistoneH3 (06-570 Millipore, Billerica), 1:300; Keratin 5 chicken antibody (SIG-3475, 
Covance, Princeton), 1:500 dilution; Keratin 10 rabbit antibody (PRB-159P, Covance, 
Princeton), 1:300 dilution; Par3 rabbit antibody (07-330, Millipore, Billerica), 1:500 
dilution; ZO1 and Occludin, (kindly provided by Pedro L. Majano, Hospital 
Universitario de la Princesa, Madrid) , 1:500. 
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1.   Characterize the epidermis of the 
K14CreERT2; AurkA∆ep/∆ep and K14CreERT2; 
AurkA∆ep/+ mice during skin development  
 
It has been recently documented that the complete loss of AurkA during epidermal 
development results in cell growth arrest and genomic instability (Torchia et al., 2013), 
hindering the probability to explore other potential functions of AurkA in epidermis.  
In this project, by partially decreasing the expression of AurkA in epidermal development, 
we aimed to explore new AurkA facets at early stages of epidermal differentiation, and 
compare them to control mice with a homozygous loss of AurkA as well as controls. 
In order to uncouple the defects arising from genomic instability from those related to 
other roles of AurkA, we decided to investigate the effect of the loss of AurkA shortly after 
the specific ablation of AurkA in the epidermis, using the K14CreERT2 inducible mouse 
system, both in AurkA homozygous (K14CreERT2; AurkA∆ep/∆ep) and heterozygous 
(K14CreERT2; AurkA∆ep/+) scenario. This provided us with a powerful system to explore 
the initial consequences of the partial loss of AurkA during skin development. 
 
 
1.1. Kinetics of the genetic recombination event in 
K14CreERT2; AurkA∆ep/∆ep and K14CreERT2; 
AurkA∆ep/+ mice upon Tamoxifen administration 
during skin development  
  
The K14-CreERT2; AurkAlox/lox mice were previously generated (Pérez	  de Castro, 2013) 
using the AurkAlox conditional allele (Cowley et. al, 2009) and the K14-CreERT2 
transgene (Metzger et. al, 2005). This model allows the conditional ablation of AurkA in 
Keratin 14 (K14)-expressing tissues (including skin epidermis), upon tamoxifen 
administration. Since our objective was to test whether the loss of AurkA affects the 
apical-basolateral polarity during skin morphogenesis, we first validated the occurrence of 
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the gene recombination events at different time points of epidermal development before 
birth. The stratification of the epidermis occurs at E14.5-E15.5. For this reason, pregnant 
females were administered daily intraperitoneal (IP) injections of tamoxifen, starting from 
the E11.5 (day post coitum). Embryos were collected from E14.5 to the latest 
developmental E18.5 stage (Figure 3A). PCR analysis of the embryo DNA confirmed the 
presence of the lox alleles, as well as the AurkA deletion after tamoxifen injections (Figure 
3B). Although the characterization of the K14CreERT2; AurkAlox/lox model in the adult 
mouse tissues has been published (Perez de Castro et al, 2013), we needed to characterize 
the model in the embryos. To further determine the timing of the Cre recombination 
event, K14CreERT2; AurkAlox/lox mice were crossed with the Rosa26LacZ reporter mice. 
Pregnant females were injected with tamoxifen, as indicated above, and the embryos were 
collected at E13.5, E14.5, E15.5 and E16.5. Then, the activity of ß-galactosidase was 
analyzed in frozen embryo sections, resulting in the appearance of the blue color, which 
indicates the occurrence of the Cre recombination event, which in our system started at 
E14.5 (Figure 3C). 
 
 
1.2. Levels of AurkA in AurkA∆ep/∆ep and AurkA∆ep/+ 
epidermis during development 
 
To further analyze the earliest developmental stage in which the levels of AurkA were 
reduced in our system, we performed immunohistochemical analyses of AurkA in the skin 
of mouse embryos collected at different developmental time points (Figure 4A). AurkA 
positive cells in the epidermis were counted and quantified for three time points: E14.5, 
E15.5, and E16.5 (Figure 4B). These results showed that there was a significant decrease 
of the levels of AurkA in the epidermis of both heterozygous and homozygous embryos, 
compared to their control counterparts, which started from E14.5. 
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Figure 3 Analysis of the occurrence of genetic recombination events in the 
K14CreERT2+/T; AurkA∆ep/+ mice during skin development. A) Schematic 
representation of the protocol for the ablation of AurkA in mouse embryos. Daily tamoxifen 
injections were given to pregnant females, starting from E11.5 dpc, until the day of embryo 
collection. B) PCR analysis of the lox and deleted lox alleles in the embryos after the 
administration of tamoxifen. C) Presence of ?-galactosidase activity in the AurkAlox/+ control 
and K14 CreERT2+/T; Rosa26LacZT/T (heterozygous) embryos induced by tamoxifen. The blue 
color indicates the presence of ?-galactosidase activity, which started appearing at E14.5. (n= 4 
mice, 2 separate litters) epi: epidermis, der:  dermis. Scale bar: 20 µm. 
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Figure 4 AurkA levels are reduced in the mouse embryo epidermis after tamoxifen 
administration. A) Representative images of the immunohistochemical analyses performed in 
in the epidermis of AurkAlox/lox (control), AurkA∆ep/+ (heterozygous), and AurkA∆ep/∆ep 
(homozygous) mice at day E15.5, after 5 daily tamoxifen injections of pregnant females. epi: 
epidermis, der: dermis. Scale bar: 100µm B) Quantification of AurkA positive cells in the 
epidermis of control, heterozygous, and homozygous epidermises at E14.5, E15.5, and E16.5. For 
each experimental group, AurkA positive cells in the epidermis were counted. Data represents 
numbers of positive cells per 20x fields (n=3 embryos from different litters, 8 20x fields each). 
cont: control, het: heterozygous, hom: homozygousE14.5 **p= 0.0083, 0.0022. E15.5 and E16.5 
***p>0.0001. 
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1.3. Heterozygous loss of AurkA in the developing 
epidermis does not result in any apparent 
macroscopical defects, but leads to a transitory 
hyperplastic phenotype in the epidermis 
 
Macroscopic analysis of E14.5, E15.5 and E16.5 embryos with heterozygous AurkA loss in 
the epidermis revealed the absence of any obvious macroscopic defects (Figure 5A). As 
expected, the AurkA null  embryos in skin exhibited a translucent skin, with areas of skin 
loss, as well the absence of whiskers and eyelids. This was in agreement with the previous 
documented observations in embryos with AurkA null epidermis, using K14Cre transgenic 
mice, in which Cre is expressed in a constitutive manner  (Torchia et al., 2013) 
 
 
 
Figure 5	  Heterozygous loss of AurkA  
in skin during epidermal 
development does not result  in any 
apparent macroscopical defects. 	  
Macroscopic images of AurkAlox/lox 
(control), K14CreERT2; AurkA∆ep/+ 
(heterozygous), and K14CreERT2; 
AurkA∆ep/∆ep (homozygous) embryos at 
different developmental stages. The arrow 
denotes the absence of eyelids in the 
conditional AurkA null embryos in skin. n= 
3. 
 
 
To examine more closely the consequences of the loss of AurkA in the developing 
epidermis, we performed Hematoxylin and Eosin (H&E) histological analyses of embryos 
with AurkA heterozygous and homozygous loss in skin (E14.5 to E18.5). Strikingly, the 
AurkA heterozygous epidermis at E14.5, E15.5, and E16.5 exhibited patches of 
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hyperplastic areas distributed across the epidermis, growing as columnar units (Figure 6A), 
which decreased as skin development progressed. As expected, the AurkA homozygous 
loss in the epidermis lead to a hypoplastic phenotype compared to controls (Figure 6A). 
Among all embryos with AurkA heterozygous loss in skin, 64% of E15.5 and 22% of 
E16.5 presented the hyperplastic skin phenotype, which was not observed at later 
developmental stages (Figure 6B). The quantitative analyses of the average of the global 
epidermal thickness of E15.5 and E16.5 AurkA heterozygous skin, revealed a trend in the 
increase across the whole epidermis, which was statistically significant (Figure 6C). Since 
progenitor cells are distributed in columnar units, these results suggests a defect in the 
columnar expansion of progenitor cells in the epidermis (Ghazizadeh and Taichman, 
2001)  
 
 
1.4 Heterozygous loss of AurkA in the developing 
epidermis leads to a transitory increase in the 
proliferation of basal progenitor cells  
 
We hypothesized that the hyperplastic phenotype observed in AurkA heterozygous 
epidermis was due to a proliferation and differentiation misbalance of epidermal 
progenitor cells. To test this hypothesis, we first analyzed the levels of proliferation at the 
three developmental stages in which hyperplasia was observed (E14.5, E15.5, and E16.5). 
To this end, IP injections of BrdU were given to pregnant females 3 h before collecting 
the embryos. This was followed by IF analysis of BrdU in skin. The proliferation levels 
were determined by counting cells with incorporated BrdU (Figure 7A).  
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Figure 6 The heterozygous AurkA epidermis exhibits a transitory hyperplastic 
phenotype at early developmental stages A) H&E histological analyses of the AurkAlox/lox 
(control), K14CreERT2; AurkA∆ep/+ (heterozygous), and K14CreERT2; AurkA∆ep/∆ep 
(homozygous) mice epidermis, at 5 consecutive days of development. Black brackets indicate a 
representative hyperplastic area in the E15.5 AurkA heterozygous epidermis. epi: epidermis, der: 
dermis, Scale bar: 40µm, n=between 7 and 10 embryos ) B) Total number of embryos with 
heterozygous loss of AurkA in the skin collected, and the percentage of the number of embryos 
exhibiting the hyperplastic skin phenotype. C) Quantification of epidermal thicknesses across 
different areas across the backskin of embryos  (n=3 embryos, 4 20x fields per embryo, 5 
measurements per field):***p< 0.0001. 
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Figure 7 The heterozygous loss of AurkA in the epidermis leads to an increase in 
cell proliferation at early stages of epidermal development A) Quantification of 
BrdU/K5 positive cells in the epidermis of AurkAlox/lox (cont), K14CreERT2;AurkA∆ep/lox (het), 
and K14CreERT2;AurkA∆ep/∆ep (hom) embryos. Pregnant, tamoxifen treated females were 
injected with 100ug of BrdU 3 h before the embryo collection. Frozen embryo sections were then 
immunostained for BrdU and K5 and, so that only the basal, proliferating cells with incorporated 
BrdU can be counted. n=30 20X fields of the backskin of 3 different embryos, per experimental 
group, E14.5: *p=0.034; E15.5 and E16.5:***p< 0.0001 B) Quantification of PHH3/K5 positive 
cells, using the same embryos and quantification method as used for BrdU. E14.5:***p< 0.0001, 
E15.5:**p=0.0033; E16.5:**p=0.0023, ***p< 0.0001. 
 
The quantification revealed a significant increase of the BrdU/K5 positive cells in the 
AurkA heterozygous epidermis at E14.5 and E15.5, while as expected, the homozygous 
loss of AurkA in epidermis led to a significant decrease, compared to controls.  
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To further validate these results, we performed Phospho Histone H3 (PHH3) stainings, to 
label cells in mitosis. Notably, consistent with our BrdU analyses, at E15.5 AurkA 
heterozygous epidermises also presented an elevated mitotic index, which decreased as 
skin development progressed (Figure 7B).  
 
 
Figure 8 The heterozygous 
AurkA epidermis exhibits 
expanded areas of basal 
and differentiated layers 
A) Representative IF images of 
epidermises co-stained with the 
basal marker K5 and spinous 
marker K10 B) Representative 
images of epidermises 
costained with the basal marker 
K5 and late-differentiation 
marker Filaggrin in AurkAlox/lox 
(control), 
K14CreERT2;AurkA∆ep/lox 
(heterozygous), and 
K14CreERT2; AurkA∆ep/∆ep 
(homozygous) embryos at 
E14.5, E15.5, and E16.5. epi: 
epidermis, der: dermis. Scale 
bar: 20 µm. 
 
 
 
 
To test whether the AurkA heterozygous epidermis also exhibited alterations in the 
terminal differentiation program, we performed IF analysis of differentiation markers. 
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The basal progenitor layer marker K5 as well as the spinous layer marker K10 were 
slightly expanded in areas of hyperplastic columnar growth (E14.5 and E15.5). Of note, 
there were no significant differences in the intensity of the fluorescent signal. Consistent 
with the previously documented phenotype, the AurkA null epidermis exhibited a 
hypoplastic phenotype with alterations in stratification and a delay in epidermal 
differentiation (Torchia et al., 2013), compared to controls (Figure 8A). 
Interestingly, no alterations in the expression of the later differentiation marker Filaggrin 
at the corresponding E16.5 skin developmental stage were observed in the AurkA 
heterozygous epidermis, compared to their control counterparts. These results suggest 
that despite the increase in proliferation, the differentiation program was not delayed, 
probably to maintain the proliferation/differentiation balance to sustain skin homeostasis  
(Figure 8B).  
Globally, these results suggest that the heterozygous loss of AurkA in the epidermis leads 
to an increase in cell proliferation shortly after its reduction at early developmental stages.  
This wave of proliferation seems to be later balanced by a proper differentiation program 
of skin.  
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2.   Investigate the role of AurkA in the 
regulation of apical- basolateral polarity in 
epidermal cells, both in vivo and in vitro	  
	  
  2.1.   Distribution of phospho Aurora kinase A (pAurkA) in  
           mouse epidermis during development and in cultured 
           primary keratinocytes 
 
The transient hyperplastic phenotype observed in the AurkA heterozygous embryo 
epidermis was greatly intriguing. So far, no studies have shown that partial loss of AurkA 
in skin can lead to hyperproliferation, which seemed not to be due to the accumulation of 
genomic instability. Therefore, we decided to explore this novel observation.  
While analyzing the differentiation status of the hyperplastic epidermis, we found that the 
hyperplastic areas were not simply an expansion of the epidermis, but the epidermis also 
appeared to be often disorganized, with different epidermal layers intermingled (Figure 
9A). Similar phenotypes have been observed in Drosophila epithelia, when certain polarity 
proteins were depleted. Epithelial tissues of these flies not only presented hyperplasia, 
such as in the case of other tumor suppressors, but also a loss of the epithelial architecture 
(Bilder, 2004). Additionally, due to the previously published implications of AurkA in the 
process of cell polarity, we decided to further explore the possibility of AurkA playing a 
role in the regulation of the epithelial apical-basolateral polarity properties of epidermal 
cells, which could perhaps explain the observed phenotype in vivo. 
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Figure 9 pAurkA is expressed at the cell cortex in both basal and differentiated 
layers of the embryo epidermis A) Representative images of the immunofluorescence 
co-staining for K10 and K5 with magnification insets showing the intercalation of the basal and 
suprabasal layers in AurkA heterozygous embryo epidermis B) Immunofluorescence co-stainings 
of pAurkA and the basal layer marker K5 in control E15.5 epidermis. The arrow indicates the 
predominant suprabasal distribution of pAurkA. Scale bar: 20 µm C) Immunofluorescence 
staining of pAurkA in the epidermis of AurkAlox/lox(control), K14CreERT2;AurkA∆ep/+ 
(heterozygous), and K14CreERT2;AurkA∆ep/∆ep (homozygous) embryos at E14.5 and E15.5. epi: 
epidermis, der: dermis. Scale bar: 20 µm D) Representative image of a mitotic cell in the basal 
layer, stained for pAurkA in E15.5 epidermis. The arrows point to the centrosome, a bona-fide 
localization of pAurkA during cell division. Scale bar: 10 µm. 
 
To examine where active AurkA localizes in the skin, we performed IF stainings for the 
active form of AurkA, phospho AurkA (pAurkA), both in the epidermis and in 
keratinocytes growing in vitro. In control epidermis, the IF signal of pAurkA was present in 
the apical area of basal progenitor cells, and around the whole cell cortex in epidermal 
postmitotic differentiated layers, suggesting a non-mitotic role of AurkA (Figure 9B). 
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Intriguingly, this localization mirrors that of the polarity proteins aPKC and Par3 in skin. 
Also, there was a significant reduction of the signal in the case of all the mutants, 
indicating that the pAurkA signal is specific (Figure 9C).  
 
Next, we investigated the localization of pAurkA in keratinocytes growing in vitro. As 
observed in vivo, pAurkA localized to the centrosomes in dividing keratinocytes. We later 
stimulated the differentiation of keratinocytes with Ca++, which also induces the 
formation of cell-cell junctions. After 24 h under these conditions pAurkA localized to the 
cell cortex (Figure 10A and B). To further validate the novel finding of the cortical 
localization of AurkA, we transfected differentiated and non-differentiated keratinocytes 
with GFP-AurkA and GFP-control constructs, and we observed that the GFP-AurkA 
signal in differentiated keratinocytes was present at the cell cortex, while in 
undifferentiated keratinocytes it was found at the centrosomes of dividing cells (Figure 7C). 
These results, once again imply a non-mitotic role of AurkA in mouse keratinocytes.  
 
To further validate the specificity of the AurkA signal in keratinocytes, we induced the 
ablation of AurkA with tamoxifen in growing K14CreERT2; AurkAlox/lox keratinocytes. 
The treatment led to a significant decrease of pAurkA at the cell cortex of differentiated 
keratinocytes (Figure 7D). We also treated the cells with the specific pAurkA inhibitor 
MLN8237-Alisertib for 12 h. This treatment caused a complete loss of the pAurkA signal 
at the cell cortex (Figure 7E). This treatment also led to a decrease in the number of 
mitotic cells, and an increase in DNA content, confirming the efficacy of the inhibitor 
(data not shown). All together, these results suggest that in mouse skin epidermis, as well 
as in in vitro keratinocytes, pAurkA is expressed at the cortex of non-proliferating cells, 
suggesting a possible non-mitotic role for AurkA.  
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Figure 10 pAurkA localizes at the cell cortex in differentiated keratinocytes in vitro 
A) IF analysis of the distribution of pAurkA in wild-type proliferating keratinocytes (arrows 
indicate the localization of the pAurkA signal at the centrosomes of a dividing cell. Scale bar: 
10µm B) pAurkA in wild-type differentiated keratinocytes, where cells were grown in normal-
calcium media for 12 h to induce differentiation C) A proliferating wild-type keratinocyte 
expressing AurkA-GFP at the centrosomes (indicated by the arrows. Wild-type differentiated 
keratinocytes expressing AurkA-GFP and GFP alone. The magnified insets indicate the cortical 
localization of AurkA-GFP  D) pAurkA staining in control (AurkAlox/lox) and tamoxifen treated 
(AurkA-/-) keratinocytes and the western blot showing the total AurkA levels after 24 h of 
tamoxifen treatment E) pAurkA distribution in differentiated wild-type and AurkA-inhibitor 
treated, keratinocytes. Scale bar: 20 µm. 
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2.2. AurkA deficiency or inhibition leads to the 
mislocalization of the apical-basolateral cell polarity 
proteins aPKC and Par3 both in vivo and in vitro 
 
To test whether AurkA plays a role in the regulation of apical-basolateral polarity in the 
epidermis of developing embryos, we first examined the bona-fide markers of polarity, 
components of the Par complex, Par3 and aPKC (Figure 11 A and B). Consistent with 
previous results, the two proteins are localized apically in basal progenitor cells, and 
around the whole cell cortex of differentiated suprabasal cells. Interestingly, in AurkA 
heterozygous and null epidermis this localization was aberrant, and the signal was more 
diffused in the cytoplasm (Figure 11A and B), suggesting that AurkA may play a role in 
the proper distribution of these polarity determinants in the epidermis.  
 
Figure 11 AurkA deficiency 
leads to the aberrant 
localization of the polarity 
proteins Par3 and aPKC in 
the embryo epidermis  
A) Representative images of 
epidermal IF stainings of the apical 
proteins Par3 and B) aPKC in the 
AurkAlox/lox (control), 
K14CreERT2;AurkA∆ep/lox 
(heterozygous), 
and K14CreERT2;AurkA∆ep/∆ep 
(homozygous) embryos at E15.5. 
epi: epidermis, der: dermis Scale 
bar: 20 µm. 
 
To test whether these events 
were cell autonomous, we 
analyzed the localization of 
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aPKC and Par3 in K14CreERT2; AurkAlox/lox primary keratinocytes upon treatment 
with tamoxifen or with the MLN8237-Alisertib pAurkA inhibitor (Figure 12A and B). 
The loss of inhibition of AurkA led to the disruption of the cortical localization of these 
two polarity proteins (Figure 12A and B). This effect was not only due to alterations in the 
distribution of these proteins, but also to a decrease in their protein levels as observed by 
immunoblot analysis (Figure 9 C).  
 
 
Figure 12 Loss or inhibition of AurkA 
in vitro leads to the mislocalization 
and reduction in the protein levels of 
the polarity proteins Par3 and aPKC 
in differentiated keratinocytes 
 A) Representative images of the IF analysis 
of aPKC and B) Par3 in differentiated 
keratinocytes treated with either tamoxifen 
or the pAurkA inhibitor. Cells were treated 
with tamoxifen for 24 h or with the AurkA 
inhibitor for 12 h, under Low Calcium 
conditions, followed by the addition of NC 
media supplemented with either tamoxifen 
or the AurkA to trigger cell differentiation. 
24 h later cells were fixed and analyzed. 
Scale bar: 40 µm . C) Biochemical analysis 
of Par3 and aPKC proteins, using the lysates 
of the cells treated using the protocol 
described above. 
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2.3. AurkA deficiency or inhibition perturbs AJ and TJ 
formation 
 
Some of the key components that work in concert with the cell polarity machinery are AJs 
and TJs. As mentioned in the introduction, studies have shown that polarity proteins and 
the junctions are important for each other’s functions. Therefore, as we hypothesize that 
AurkA may behave as a polarity protein in the epidermis; we decided to study its 
involvement in the formation of AJs and TJs. We first evaluated the distribution of AJs 
proteins in AurkA heterozygous and AurkA null embryo epidermis. For this, we stained 
for ECAD, a transmembrane protein  of the AJ complex (Figure 13). In both AurkA 
heterozygous and homozygous epidermis, ECAD was more diffused, compared to the 
cortical localization observed in controls. Moreover, the signal was significantly reduced 
in the basal layer of the epidermis, indicating possible aberrations in AJ formation and/or 
stability. Interestingly, the phenotype observed was not only restricted to the hyperplastic 
patches of the heterozygous embryos, but was also present in areas that were not 
hyperplasic.  
 
Figure 13 
Heterozygous and 
homozygous AurkA 
embryo epidermis 
presents aberrant 
localization of ECAD 
Representative images of 
IF analysis of ECAD in 
the epidermis of 
AurkAlox/lox (control), 
K14CreERT2;AurkA∆ep
/lox (heterozygous), and 
K14CreERT2;AurkA∆ep
/∆ep (homozygous) 
embryos at E15.5.  
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To investigate if the loss of AurkA caused alterations in the establishment of AJs, we 
turned to in vitro studies. To this end, we performed calcium switch experiments, where 
the addition of normal calcium media induces AJ formation in confluent keratinocytes 
(Figure 14A and B). In control cells, after 24 h of calcium switch, AJs were already formed, 
as denoted by the presence of ECAD at the cell-cell contacts. However, tamoxifen or 
AurkA inhibitor treated cells exhibited a significant delay in the formation of AJs (Figure 
14A and B). Biochemical analyses showed that after 12 h of calcium switch both 
tamoxifen and inhibitor treated cells had significantly decreased levels of ECAD, as 
compared to controls (Figure 14C).  
Next, we analyzed the consequences of the loss or inhibition of AurkA in TJ formation, 
using the tight junction marker Occludin. We observed that both AurkA deficient and 
AurkA inhibited cells were unable to form TJs (Figure 15A). Interestingly, however, 
unlike ECAD, the protein levels of Occludin were not changed compared to controls 
(Figure 15B). It is well established that defects in TJs lead to the loss of the epithelial 
barrier. For this reason, we wanted to test whether the AurkA heterozygous and null 
embryo epidermis presented skin barrier defects. To this end, we performed permeability 
barrier assays, and as expected, both embryos with heterozygous and homozygous loss of 
AurkA in the epidermis exhibited a severe barrier defect (Figure 16).   
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Figure 14 Loss or inhibition of AurkA leads to a delay in AJ formation and 
downregulation of ECAD A) Representative images of IF analysis of ECAD of cells pretreated 
with the AurkA inhibitor or DMSO as control for 12 h, followed by calcium switch in the 
presence of the treatments and analyzed after 0.5 h, 2 h and 12 h B) IF analyses of ECAD in cells 
pretreated with tamoxifen for 12 h and analyzed at different time points after calcium-switch in 
the presence of tamoxifen (1 h, 6 h, and 24 h) C) Biochemical analysis of ECAD using the lysates 
of the cells treated using protocols described above, after 24 h of calcium switch. Scale bar: 40 µm. 
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Figure 15	  AurkA loss or inhibition leads to tight junction formation delay in vitro 
A) Representative images of the IF analysis of Occludin after the calcium switch experiment, 
where control (DMSO) and inhibitor or tamoxifen treated cells were added normal calcium 
media for different lengths of time (1 h, 6 h, and 24 h), after being treated with tamoxifen for 24 h 
or inhibitor for 12 h. B) Biochemical analysis of E-cad using the lysates of the cells treated using 
the same protocol as described above. Scale bar: 40 µm  
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Figure 16 AurkA deficiency in the 
epidermis leads to barrier defects In 
the barrier-permeability assay, the blue 
color indicates the penetrance of the 
bromophenol blue dye through the skin. 
Note the dye penetrance in embryos with 
AurkA deficient skin, at E17.5 and E18.5, 
in which the barrier should have already 
been formed (n=4 embryos). 
 
 
 
 
 
 
 
2.4. AurkA deficiency leads to defects in orientation of the 
spindles of dividing cells 
 
The establishment and maintenance of apical-basolateral polarity is tightly related to the 
orientation of cell divisions. To explore this, we monitored the presence of dividing basal 
progenitor cells and the orientation of their cell divisions by costaining embryo 
epidermises with K5 and PHH3 (Figure 17A and B). Parallel and perpendicular cell 
divisions were counted in both controls and AurkA heterozygous epidermis in E14.5 and 
E15.5 embryos that presented the hyperplastic phenotype. Only the AurkA heterozygous 
epidermises were quantified, since the AurkA null epidermis exhibited extremely low 
number of PHH3 positive cells. For the quantifications, only the cells with clear parallel 
or perpendicular orientation, in relation to the basement membrane were considered.  
Quantification of parallel vs. perpendicular divisions revealed that in the E14.5 AurkA 
heterozygous epidermis there was an increase in the occurrence of perpendicular cell 
divisions, which could explain the early expansion of differentiated layers (Figure 8A). In 
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E15.5 embryos, we observed an increase of parallel cell divisions, which could explain the 
bias towards symmetric cell divisions and the expansion of the proliferative layer. It is 
important to note that the ratios between parallel and perpendicular divisions in the 
control E14.5 and E15.5 embryos are consistent with previously published observations 
(Lechler and Fuchs, 2005). 
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Figure 17 E14.5 and E15.5 AurkA heterozygous embryo epidermises present 
misoriented cell divisions A) Representative images of cells dividing parallel and 
perpendicular to the basement membrane, as indicated by the arrows. PHH3 staining is used to 
visualize the orientation of the plane of cell division and K5 staining was used as a reference for 
the division angle. Scale bar: 5µm B) Quantification of the parallel, perpendicular, and all other 
orientation divisions in the epidermis of AurkAlox/lox (control) and K14CreERT2;AurkA∆ep/lox (het) 
embryos (E14.5 and E15). PHH3/K5 positive cells in the backskin epidermis that exhibited a 
clear orientation of the plane of cell division were counted. All PHH3/K5 positive cells were 
counted and categorized into those dividing parallel to the basal membrane, perpendicular to the 
basal membrane, and all the other orientations. Significance values refer to the comparison of the 
perpendicular division fraction p= 0.0140, (n=3, approx. 40 cells counted). 
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2.5. Mechanisms by which AurkA may regulate apical-
basolateral polarity 
 
So far we have demonstrated that loss of AurkA leads to loss of cell polarity in vivo and in 
vitro. Polarity markers, such as Par3 and aPKC, as well as AJs and TJs were disrupted 
when AurkA levels are reduced or its functional activity is inhibited. To decipher the 
hierarchy of these defects, we first explored what happens when aPKC is inhibited. To 
this end, we treated differentiated keratinocytes with a specific aPKC inhibitor. Under 
these conditions, pAurkA remained localized at the cell cortex, indicating that it functions 
upstream of the Par complex, as demonstrated in other systems (Figure 18A). However, 
there was a delay in the formation of AJs, similar to the one observed in the absence of 
AurkA, although not as severe (Figure 18B), suggesting that the Par complex is upstream 
of AJs formation in keratinocytes. Next, to explore whether AJs can also modulate the 
cortical localization of pAurkA, we analyzed its localization in ECAD KO; PCAD 
shRNA keratinocytes (Tinkle et al., 2008). First, we confirmed by IF analysis that the cells 
were negative for both ECAD and PCAD (Fig. 19A and B), and that were also unable to 
form TJs, as published before (Tinkle et al., 2008) (Figure 19A). Interestingly, we observed 
that in the absence of ECAD and PCAD, pAurkA was unable to localize to the cell cortex 
after calcium switch. This suggests that pAurkA localization is dependent on cell-cell 
adhesion events. Together, these data suggest that pAurkA and cell junction formation 
are codependent, and that the Par complex proteins are part of this interaction. 
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Figure 18 The inhibition of aPKC does not affect the cortical localization of pAurkA, 
but leads to a delay in AJ formation A) Representative images of IF stainings of pAurkA and 
B) ECAD localization in keratinocytes after treatment with 1µM aPKC inhibitor for 9 h, before 
differentiating them in normal calcium media for 24 h in the presence of the aPKC inhibitor, 
Scale bar: 40 µm. 
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Figure 19 The cortical localization of pAurkA is dependent on AJ formation A) 
Representative images of IF stainings of ECAD and Occludin in control and ECAD KO; PCAD 
shRNA keratinocytes, Scale bar: 40 µm B) PCAD IF analysis in control and ECAD KO; PCAD 
shRNA keratinocytes C) Control and E-cad KO; P-Cad shRNA cells stained for pAurkA and 
aPKC after differentiation. For all stainings cells were differentiated in NC media for 24 h before 
fixation, Scale bar: 40 µm. 
 
 
 
 
 
 
 
	   	  
	  
	   80	  
2.6.  AurkA also regulates additional aspects of cell 
polarity in epithelial keratinocytes  
 
Many polarity protein complexes have evolved to play a role during different kinds of cell 
polarity. In order to test whether AurkA may also behave in a similar way, we explored 
the effects of the AurkA deficiency on the front-rear polarity, a type of polarity important 
for the directional movement of cells. To address this question, we performed a scratch 
assay, where a scratch was make onto a monolayer of confluent keratinocytes, and the 
keratinocytes were allowed migrate to fill in the ‘wound’. 9 h later, migrating 
keratinocytes should have acquired front-rear polarity. As a result of this polarity, 
organelles, such as Golgi become oriented towards the leading edge, facing the ‘wound’. 
Therefore, after the scratch assay we stained the Golgi and counted the number of cells at 
the leading edge with oriented (towards the leading edge) and misoriented (any other 
direction) organization (Figure 20A). AurkA heterozygous keratinocytes presented an 
increase in the number of cells with misoriented Golgi, suggesting a problem in cell 
polarization during migration (Figure 20B). To confirm the observed phenotype, we 
performed a cytoochip experiment where cells are plated on fibronectin micropatterns to 
which they attach and acquire an ‘umbrella’ shape that forces the cells to acquire a front-
rear polarity, that mimics the situation during cell migration (Figure 10C). Similar to the 
scratch assay, we stained the Golgi and counted the number of control and AurkA 
heterozygous keratinocytes that exhibited an oriented or misoriented Golgi (Figure 20D).  
Interestingly, there was also a significant increase in the number of AurkA heterozygous 
keratinocytes displaying a misoriented-Golgi, compared to controls. The two experiments 
could not be performed with the AurkA null keratinocytes, since replating the cells after 
treatment with tamoxifen led to a great cell loss. 
 
 
 
 
 
	   	  
	  
	   81	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20 AurkA heterozygous keratinocytes exhibit aberrations in front-rear cell 
polarity in vitro A) Representative images of IF analysis of the Golgi, 9 h after a scratch was 
made onto the cell monolayer. White arrows denote a properly oriented Golgi towards the 
leading edge, and the red arrow a cell with a misoriented Golgi B) Quantification of keratinocytes 
at the leading edge with misoriented Golgi. AurkAlox/+ (control) and AurkA-/+ (heterozygous) cells 
(n=3 experiments). ***,p< 0.0001 C) Representative images of keratinocytes plated on cytoochips 
coated with fibronectin, stained with a Golgi marker and for AurkA. Scale bar: 5µm D) 
Quantification of cells presenting a misoriented Golgi in control and heterozygous 
cells.*p=0.0188. 
 
2.7. Deficiency of AurkA also leads to apical-basolateral  
polarity defects in the gold standard MDCK model of 
cell polarity 
 
Our studies have uncovered a previously unappreciated role of AurkA in the regulation of 
the apical-basolateral polarity of epidermal cells. To validate that this role is also observed 
in other cellular systems, we took advantage of the gold-standard cell model system of 
apical-basal polarity, MDCK cells. First, we analyzed if pAurkA also distributed to the 
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cell cortex in MDCK cells (Figure 21A). We then performed knock down (KD) 
approaches to reduce the levels of AurkA by transfecting MDCK cells with a cocktail of 
two siRNAs specific for AurkA, in addition to include transfections with scramble controls. 
Upon AurkA KD, the signal of pAurkA at the cell cortex of MDCK cells was significantly 
reduced. The same was observed when the cells were treated with the specific AurkA 
inhibitor (Figure 21B). 
 
 
 
 
Figure 21 pAurkA localizes at the cell cortex of MDCK cells A) Representative images of 
IF stainings for pAurkA in control and AurkA KD MDCK cells. B) pAurkA staining in control 
(DMSO) and MDCK cells treated with the pAurkA inhibitor for 12 h. Scale bar: 40 µm. 
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To test if AurkA deficiency leads to aberrations in the localization of proteins of the Par 
complex, we analyzed the distribution of aPKC and Par3 in both AurkA-KD and AurkA 
inhibitor-treated cells (Figure 22A and B). Reductions of AurkA led to the mislocalization 
of aPKC from the cell cortex. However, interestingly it did not seem to affect the 
localization of Par3.  
We also took advantage of the 3-D MDCK cysts model system, in which cells growing on 
matrigel are induced to form tubular structures with well-defined features of cell 
polarization. Since AurkA KD cysts were arresting in mitosis, and since we wanted to 
uncouple the mitotic defect from the polarity one, we treated late-stage cysts (day 4) with 
the specific AurkA inhibitor, for only 10 h (Figure 23A). In comparison to rounded 
control cysts displaying lumens, the inhibitor treated ones presented very irregular shapes 
and protrusions, in addition to an increase in the number of lumens. We were also 
interested to see if the loss of AurkA in MDCK cells also induced a delayed in AJ 
formation. To this end, we performed calcium switch experiments and observed a clear 
delay in the formation of AJs in AurkA KD cells when compared to controls (Figure 23A). 
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Figure 22 AurkA KD or inhibition of AurkA lead to the mislocalization of  aPKC and 
PAR3 in MDCK cells A) Representative images of IF analysis of aPKC and B) Par3 in KD and 
inhibitor treated MDCK cells. Scale bar: 40µm 
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Figure 23 3-D MDCK cysts present an aberrant organization in the presence of an 
specific AurkA inhibitor A) Representative images of the control and inhibitor-treated 
MDCK cysts stained for β-catenin, which allows for the visualization of the cyst shape. Cysts were 
allowed to form for 72 h after plating the cells, followed by the addition of the AurkA for 18 h 
before fixation. B) IF staining for aPKC in control and inhibitor treated cysts. C) Quantification 
of the number of cysts with single lumens. *p=0.0121. Over 100 cysts were counted, n=2, number 
of experiments.  
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Figure 24 KD of AurkA in MDCK cells causes a delay in AJ formation. A) 
Representative images of IF analysis of ECAD after 2 h and 12 h of calcium switch, in control 
AurkA KD cells. Scale Bar: 40 µm. 
 
  
2.8. Insights on the consequences of the heterozygous loss 
of AurkA in epidermal tumorigenesis 
 
One of the interesting facets of our results is the requirement of fine-tuned levels of AurkA 
to sustain skin homeostasis. We observed that the heterozygous loss of AurkA in embryo 
epidermis led to a transient wave of hyperproliferation associated to alterations in cell 
polarity. This scenario differed from the one observed in embryos with homozygous loss 
of AurkA in the epidermis, which led to hypoplasia and a decrease in cell proliferation. 
The hyperplastic phenotype points to the possibility that partial losses of AurkA could 
possibly play a tumor-promoting role in the epidermis. We wanted to further explore this 
question. To this end, we performed the well-defined DMBA/TPA carcinogenesis 
protocol in the epidermis of adult control and AurkA heterozygous mice (Faraldo et al., 
1997). Our preliminary results indicated a lower latency of appearance of papillomas in 
AurkA heterozygous epidermis when compared to controls, although fewer numbers of 
papillomas were observed (Figure 25). These preliminary results may resemble the more 
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physiological scenario of epidermal tumors, and point to the potential risk of only 
achieving partial reductions of AurkA in current anticancer therapies. 
 
  
 
Figure 25 Heterozygous loss of AurkA in the epidermis leads to a lower 
latency of papilloma appearance upon administration of the DMBA/TPA 
carcinogenesis protocol Mice were injected with tamoxifen for 5 consecutive days, 3 
days later DMBA was applied, followed by the administration of TPA twice a week 
during the duration of the experiment. n=2 experiments: 4 Heterozygous, 5 control mice. 
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Discussion 
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The question of how the architecture of a cell, tissue, or an organism dictates biological 
functions, and how biological functions can maintain tissue organization in a reciprocal 
manner, has been a long-lasting question for many scientists (Kirschner et al., 2000). 
Understanding this ying -yang relationship between biological structure and function will 
be fundamental to delineate how it underlies tissue homeostasis, and how when perturbed 
leads to disease stages or tissue aging. After years of research, it is becoming increasingly 
clear that changes in cellular shape and architecture can modulate tissue specific 
functions (Miller and Davidson, 2013; Guillot and Lecuit, 2013). However, the structure 
of the whole tissue or a cell depends on a well-engineered collaboration of different 
elements. In this grand design, cell polarity plays a very important role. Cell polarity 
refers to structurally, and thus functionally different domains within the cell. One type of 
polarity that has been greatly explored in eukaryotic models is apical-basolateral polarity 
in simple epithelia. Little is known, however, about this kind of cell polarity in more 
complex epithelial tissues, such as the stratified epithelial tissue of the skin, the epidermis. 
In this project we aimed to extend this knowledge, and with our findings we hope to have 
contributed to the understanding of the mechanisms that underlie apical-basolateral 
polarity in the epidermis. Our results uncovered a novel function of Aurora kinase A in 
the regulation of apical-basolateral polarity, which goes beyond its roles as a mitotic 
protein, and as a regulator of oriented cell divisions. The physiological role of AurkA in 
the context of apical-basolateral polarity has not been so far observed in other tissues. 
Our findings now open new possibilities for further examination of the precise roles of 
AurkA in the regulation of cell polarity and its implications for the maintenance of the 
physiological balance of epithelial tissues.  
 
 
1. Beyond cell division: AurkA as a novel player in the 
establishment and maintenance of apical-
basolateral polarity  
 
AurkA has proved to be a protein with a variety of roles. It has been shown to play a role 
in cellular processes other than mitosis, including cell polarity. The emerging functions of 
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AurkA in cell polarity appear to be evolutionary conserved. In the lower eukaryote 
Drosophila melanogaster, it has been shown that it regulates asymmetric neuroblast divisions 
by interacting with the Par complex (Wirtz-Peitz et al., 2008). Moreover, the distribution 
of cell fate determinants between Drosophila neural progenitors and daughter cells also 
seems to be regulated by AurkA activity (Cayouette and Raff, 2002). Interestingly, 
virtually all cell polarity proteins, including those of the Par complex, are as well 
evolutionary conserved (Siller and Doe, 2009). In mammals, AurkA has only been 
recently associated with the regulation of spindle orientations of multipotent progenitor 
cells residing in adult tissues, such as the mammary epithelia (Regan et al., 2013). 
 
In addition to this emerging role in oriented cell divisions, AurkA has also been 
implicated in the polarized growth of neurites, which facilitate the directional flow of 
signaling cues in neural cells (Yamada et al., 2010). Of note, this level of cell polarization, 
parallels apical-basolateral polarity of epithelial cells (Famulski and Solecki, 2013).   
Despite the tantalizing roles that have emerged for AurkA from these studies, the 
functional importance of this protein in the regulation of epithelial apical-basolateral 
polarity remains unclear. Hence, we hypothesized that this protein also played a role in 
apical-basolateral polarity in the skin epidermis. To address this hypothesis we used a 
genetic mouse model of conditional deletion of AurkA in epidermal cells, both in vivo and 
in vitro, as well as the pharmacological inhibition of AurkA in in vitro keratinocytes. 
 
AurkA and the Par complex  
One of the most novel findings of this study is the distribution of pAurkA to the cell cortex 
of epithelial cells. Both in vivo and in vitro, pAurkA localized not only to the apical site of 
epidermal progenitor cells, but also to the cell cortex of postmitotic differentiated 
keratinocytes, further supporting the existence of additional roles for AurkA beyond its 
mitotic roles. Moreover, pAurkA localization mirrored the localization of the Par 
complex proteins, Par3 and aPKC, and deficiency or inhibition of AurkA led to the 
mislocalization of the two Par complex proteins. Strikingly, in out system AurkA 
regulated the stability of the two proteins. We believe these results would open a new 
avenue for investigating the mechanisms through which AurkA may regulate the Par 
complex in mammalian cells. It is tempting to speculate, that similar to the models 
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proposed in Drosophila (Wirtz-Peitz et al., 2008), and in neurons (Khazaei and Püschel, 
2009), that AurkA can also function in apical-basolateral polarity via phosphorylation of 
Par proteins, allowing their distribution to specific polarized domains.  
 
AurkA and junctional stability: physiological implications in skin barrier function  
AJs and TJs are seminal components of the apical-basolateral polarity. On one hand, they 
contribute to sort the polarity complexes to their proper domains. On the other hand, 
some polarity proteins can be important for the maintenance of these adhesion complexes. 
Our results showed that deficiency or inhibition of AurkA led to delays in AJ formation, 
accompanied by a significant reduction of the protein levels of ECAD. Interestingly, 
keratinocytes mutant for both ECAD/PCAD fail to recruit pAurkA to the cell cortex. 
Together, these results indicate that upon differentiation, AurkA is necessary for the 
proper formation of AJs, and reciprocally, AJs are necessary for the cortical localization of 
AurkA. But how could AurkA regulate AJs? An interesting link that has been made in the 
previous studies is between Ajuba, an activator of AurkA, and ECAD (Nola et al., 2011). 
This study showed that loss of Ajuba led to Rac activation, which in turn destabilized 
cadherin receptors at the membrane. However, since loss of Ajuba did not lead to 
changes in the levels of ECAD, likely indicates the existence of additional mechanisms by 
which AurkA regulates ECAD protein stability. 
 
Since AJs are necessary for the formation of TJs, and ECAD protein levels were reduced, 
it was not surprising to observe a delay in TJs formation and in the recruitment of 
Occludin to the cell cortex. Interestingly, the total levels of Occludin were not changed. 
Thus, it is possible that AurkA directly regulates the stability of ECAD, which in turn 
affects TJs. To further answer this question, it would be interesting to see through which 
mechanism AurkA stabilizes ECAD protein. A possible hypothesis would be that it 
directly or indirectly phosphorylates ECAD, which leads to its destabilization and 
degradation.  
 
Next, we hypothesized that defect observed in TJs in vitro also occurs in the epidermis, in 
which the embryos with heterozygous and homozygous loss of AurkA in skin would have 
problems developing skin barrier, a process that normally starts at E16.5 (Hardman et al., 
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1998). Indeed, we found that both heterozygous and homozygous embryos presented a 
severe skin barrier defect. However, curiously enough, the AurkA heterozygous skin at 
E17.5 are able to form a partial functional barrier, compared to controls, to later lose it 
by E18.5. Probably by the accumulation of defects including reductions in the functional 
activity of AJs and TJs. It would be interesting to further address AurkA’s role, in vivo and 
in vitro, in the maintenance of apical-basolateral polarity and junction stability, after it has 
already been established.  
 
Due to the severe defects observed in AurkA deficient embryos in skin, they were always 
sacrificed by the mothers upon birth, suggesting that their phenotype must likely be 
perinatally lethal. However, this finding is intriguing, since it has been shown that mice 
with constitutive, homozygous deletion of AurkA are embryonically lethal, whereas mice 
with heterozygous constitutive deletion of AurkA survive and live until late adulthood 
(Lin-Yo, 2008). It is possible that the germline deletion of one allele of AurkA allows the 
organism to develop a compensatory adaptation, whereas the conditional ablation of the 
gene has more severe effect because cells have no time to adapt.   
 
AurkA and spindle orientation 
In an epithelial tissue, well-established apical-basolateral polarity is necessary in order for 
the cell divisions to be oriented correctly. Therefore, perturbations in apical-basolateral 
polarity are likely to lead to misorientation in spindle orientation. Our analysis of the 
spindle orientation in the embryo epidermis, show that in the AurkA heterozygous 
epidermis at E14.5 there was an increase of perpendicular cell divisions compared to 
controls, while E15.5 AurkA heterozygous embryo epidermis presented a decrease in the 
number of perpendicular cell divisions compared to controls. Of note, additional polarity 
proteins have been identified in the regulation of oriented cell divisions in the epidermis. 
These include the scaffolding proteins NuMA and Inscutable which localize to the 
suprabasal differentiating cell during asymmetric cell division. Our results resemble the 
model overexpressing the protein Inscutable in skin, where, at first an increase in 
asymmetric cell divisions was observed, but the effect is later reversed upon prolonged 
Inscutable expression, probably to achieve an equilibrium between proliferation and 
differentiation (Poulson and Lechler, 2010). This phenotype is accompanied by 
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disassociation of the protein NuMA from the apical surface. Possibly, AurkA is also 
required for the proper localization of the spindle orientation determinants. Further 
studies will probably shed light about the potential roles for AurkA in the regulation of 
oriented cell divisions via these mitotic polarity proteins in the skin.  
 
AurkA and cell polarity concepts extending beyond 
Many polarity protein complexes, including the Par complex, are conserved across 
different types of cell polarity. In order to see whether the polarity role of AurkA also 
extends further than apical-basolateral polarity in the skin epidermis, we analyzed front-
rear polarity in keratinocytes. Indeed, our results confirmed that AurkA plays a role in 
front-rear polarity, which presents a range of new possibilities for investigating how 
AurkA could be involved in this particular type of polarity. Could it control the 
cytoskeleton? 
We also wanted to tests whether the polarity role of AurkA is true in other types of 
epithelial tissues. We used MDCK cells, an example of simple epithelia, where we also 
found loss of polarity upon KD or inhibition of AurkA. These findings present a unique 
opportunity to explore the role of AurkA in polarity, exploiting MDCK cells, as a bona-
fide model of apical-basolateral polarity. This model would allow for a detailed, in vitro 
analysis of the polarity pathway in which AurkA may be involved. For example, spindle 
orientation during cyst formation would be interesting aspect analyze.  
 
2.   AurkA, apical-basolateral polarity, and cancer 
 
Although prevention, diagnostics, and treatment of cancer have improved greatly in the 
last decades, the battle against cancer remains, and there is a long way to go before we 
can understand the complexity of this disease. Before understanding the malfunction of a 
tissue, it is necessary to understand it’s homeostatic process. For this reason, it was 
interesting to find that loss of AurkA in skin epidermis can lead to an increase in 
proliferation, that was accompanied by alterations in cell polarity.  
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A wave of transitory proliferation in the AurkA heterozygous embryo epidermis 
Possibly one of the most intriguing questions that emerged from our studies was the 
presence of hyperplastic patches across the AurkA heterozygous mutant epidermis. 
Deciphering the mechanism behind the hyperproliferative phenotype would be 
challenging because in vitro AurkA heterozygous keratinocytes proliferate at the same rate 
as control keratinocytes (data not shown). One possibility is that the hyperplastic 
phenotype is the result of responding to several cues arising from the whole tissue 
macroenviroment, and not a cell-autonomous proliferative response. To this regard, it is 
known that loss of ECAD leads to increased Notch signaling and cell survival in vivo 
(Ferreira et. al, 2011). In our in vivo analysis of ECAD, the diffused signal was not 
restricted only to the hyperplastic areas of the heterozygous epidermis, suggesting that the 
loss of functional AJs indeed precedes hyperproliferation. In order to understand how the 
loss or AurkA and cell polarity can lead to hyperproliferation in the context of a tissue, it 
could be interesting to explore the role of Notch in our system.  
 
Interestingly, the epidermal hyperplastic phenotype became hypoplastic as embryos 
progressed through development (E16.5-E18.5). This resembles some previously 
published studies showing that in mammalian epidermis Myc can play both an oncogenic 
role, as well as stimulate differentiation (Watt et al., 2008). Activation of Myc leads to 
stem cell proliferation, while sustained levels of Myc activation stimulates the proliferation 
of stem cells to enter to trans-amplifying compartment and thereby initiate terminal 
differentiation. In other words, sustained levels of a proliferative cue can be converted 
into a differentiation cue. Perhaps, the phenotype we observed with AurkA heterozygous 
embryo epidermis may imply a similar mechanism. Moreover, like in the Myc-
overexpression model, AurkA heterozygous, hyperplastic epidermis also exhibited a slight 
expansion of the spinous layer, suggesting that proliferating cells were indeed induced to 
differentiate.  
 
Another intriguing observation we made was that the hyperproliferative patches found in 
AurkA heterozygous embryo epidermis very often had columnar structure, with a line of 
cells expanding upwards. Previous studies, using linear tracing experiments have shown 
that the proliferating keratinocytes are confined to distinct columnar units representing 
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epidermal proliferative units (Ghazizadeh and Taichman, 2001). Thus, our observation 
may imply that the partial loss of AurkA hyperactivates the proliferation of stem cells in 
the skin epidermis. 
 
All the AurkA homozygous embryos presented hypoplasia and decreased proliferation. 
This is probably due to the cell arrest induced by the loss of both alleles of AurkA. Thus, 
it is reasonable to speculate that partial loss of AurkA is not sufficient to cause cell-arrest, 
but is sufficient to cause hyperplasia, again suggesting that AurkA plays a role other than 
the mitotic cycle and centrosomes regulation during division.  
 
AurkA inhibition as a cancer treatment 
Aurora kinase is commonly overexpressed in multiple tumor types. Several small-
molecule inhibitors have been designed to block its function. Indeed, the AurkA inhibitor 
MLN8237 used in this study is currently in Phase 2 clinical trials for the treatment of 
stage III and IV of Melanoma. The rationale behind this treatment is to induce cell 
growth arrest, and thus combat the proliferating cancer cells. Indeed, the genetic 
depletion of AurkA in skin, in mice that develop tumors upon DMBA/TPA protocol, 
confirms the efficiency of reducing total AurkA skin levels, for treatment of tumors(Pérez 
de Castro et al., 2013). However, we believe that our findings highlight the risks of not 
achieving a complete reduction of AurkA activity, since this may have opposite effects. 
Our in vitro and in vivo data shows that loss of AurkA leads to reductions in cell polarity 
and cell junction stability. The consequences of the loss of ECAD in promoting 
tumorigenesis and epithelial to mesenchymal transition events in malignant tumors are 
well characterized (Faraldo et al., 1997). Moreover, it has been recently shown that loss of 
Par3 leads to the development of carcinomas in both epidermis and mammary epithelia 
(Iden et al., 2012; McCaffrey et al., 2012). Although preliminary, our results employing 
the DMBA/TPA carcinogenesis protocol in the AurkA heterozygous skin of adult mice 
revealed a reduction in the latency of appearance of papillomas compared to controls. 
Although this can be a combination of proliferative properties combined with the 
acquisition of genomic instability, our results suggests that further understanding is 
needed to develop effective therapies against AurkA, to avoid any possible adverse effects 
in the responsiveness of tumors.  
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In closing, by partially reducing the levels of AurkA in the epidermis, we have uncovered 
a novel role for this protein, underlying an hyperproliferative transitory response during 
skin development in a process associated with loss of apical-basal polarity. These findings 
now open new avenues for exploring the relationship between AurkA, loss of intercellular 
adhesion molecules and cell polarity, hallmarks of several human skin disorders and 
disease. 
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Conclusions 
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Objective 1: Characterize the epidermis of the K14CreERT2; AurkA∆ep/+ and 
K14CreERT2; AurkA∆ep/∆ep mice during skin development. 
a. In our system of conditionally induced AurkA ablation in the epidermis, Cre gene 
begins to be expressed at E14.5, and AurkA protein levels are significantly 
reduced in both heterozygous and homozygous embryos, confirming that the 
system works, and defining the kinetic of the genetic recombination event. 
 
b.  Heterozygous loss of AurkA in the developing epidermis does not result in any 
apparent macroscopical defects, compared to the embryos with homozygous loss 
of AurkA in skin. However, it leads to a transitory hyperplastic phenotype in the 
epidermis at E14.5-E16.5, characterized by increased proliferation and expansion 
of differentiated layers. 
 
Objective 2: Investigate the role of AurkA in the regulation of apical- basolateral 
polarity in epidermal cells, both in vivo and in vitro 
 
a. pAurkA is localized at the cell cortex in both basal and differentiated layers of the 
embryo epidermis, as well as the cell cortex of differentiated keratinocytes in vitro 
b. Loss of AurkA leads to aberrations in the localization of the Par complex proteins 
Par3 and aPKC in vivo, while in vitro, deficiency or inhibition of AurkA leads to 
downregulation of the two proteins. Inhibition of aPKC does not affect the 
localization of pAurkA at the cortex, but does lead to a delay in adherens junction 
formation. 
c. Loss of AurkA leads to reductions in adherens junctions in vivo, consistent with the 
observations made in vitro, in which the deficiency or inhibition of AurkA also 
leads to reductions of ECAD protein levels. Polarity and adhesion events are 
mutually modulated, since the loss of cadherins, in vitro, leads to the loss of the 
cortical localization of pAurkA. 
d. Deficiency or inhibition of AurkA leads to a delay in tight junction formation in 
vitro, but it does not affect the total levels of the tight junction protein Occludin. 
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e. Deficiency of AurkA in the embryo epidermis leads to misalignments of oriented 
cell divisions. 
f. Loss of AurkA leads to loss of cell front-rear polarity during cell migration. 
g. Deficiency or inhibition of AurkA in the MDCK cell system of cell polarity, also 
leads to the loss of the cortical localization of aPKC and Par3, as well loss of 
polarized cyst-formation in Matrigel, suggesting a fundamental role for AurkA in 
the maintenance of apical-basolateral polarity in epithelia. 
h. Preliminary results indicate that the heterozygous loss of AurkA, reduces the 
latency of papilloma appearance in the skin using the DMBA/TPA carcinogenesis 
model. This maybe due to a combination of the acquisition of genomic instability, 
loss of cell polarity and increased proliferation.  
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Objetivo 1: Caracterizar la epidermis de ratones K14CreERT2; AurkAΔep/+ y 
K14CreERT2; AurkAΔep/Δep durante el desarrollo embrionario. 
a. En nuestros modelos de ratón modificados genéticamente para eliminar/reducir 
los niveles de AurkA en la epidermis, el gen que codifica la enzima Cre comienza 
a expresarse en el día 14.5 del desarrollo embrionario (E14.5), y los niveles de 
AurKA se reducen significativamente tanto en ratones homocigotos como 
heterocigotos, confirmando que el sistema funciona. 
b. Los embriones AurkA heterocigotos y homocigotos presentan un fenotipo visible 
macroscópicamente el día E17.5. A nivel microscópico, en el estadío E14.5-E15.5 
ya se detectan áreas de hiperplasia en la epidermis. Los embriones heterocigotos 
que presentan dicha hiperplasia muestran además un aumento en la proliferación 
y una expansión de las capas diferenciadas de la epidermis. 
Objetivo 2: Investigar el papel de AurkA en la regulación de la formación y el 
mantenimiento de la polaridad apico-basal en células de la epidermis in vivo e in vitro.  
a. pAurkA se localiza en el cortex de las células de la epidermis embrionaria, tanto 
de las capas basales como de las diferenciadas. In vitro, pAurkA se localiza en el 
cortex de los queratinocitos diferenciados. 
b. La pérdida de AurkA conduce a una pérdida de la localización correcta de las 
proteínas Par3 y aPKC in vivo; mientras que in vitro, la ausencia o la inhibición 
química de AurkA inducen una disminución en los niveles de expresión de 
ambas proteínas. La inhibición de aPKC no afecta a la localización de pAurKA 
en el cortex celular, pero conduce a un retraso en la formación de las uniones 
adherentes. 
c. La pérdida de AurkA genera alteraciones en las uniones adherentes in vivo; 
mientras que in vitro, la ausencia o la inhibición química de AurkA inducen una 
disminución en los niveles de expresión de ECAD. Por otro lado, la pérdida de 
las cadherinas in vitro induce la pérdida de la localización cortical de pAurkA.  
d. La ausencia o la inhibición química de AurkA inducen un retraso en la formación 
de las uniones estrechas in vitro, pero no cambian los niveles de expresión de las 
proteínas de las uniones estrechas ocludina y ZO1.  
e. La pérdida de AurkA en la epidermis del embrión induce alteraciones en la 
orientación de las divisiones celulares. 
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f. La pérdida de AurkA genera alteraciones en la polaridad front-rear durante la 
migración celular.  
g. La ausencia o la inhibición química de AurkA en las células MDCK conducen a 
la pérdida de la localización cortical de aPKC y Par3, así como a la pérdida de la 
estructura polarizada de los cultivos 3D en matrigel. 
h. Después del tratamiento con DMBA/TPA, los ratones heterocigotos para AurkA 
desarrollan papilomas más tempranamente que los ratones control. 	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